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ABSTRACT OF DISSERTATION

PHARMACOLOGIC INDUCTION OF THE MELANOCORTIN 1 RECEPTOR (MC1R)
PATHWAY PROVIDES PROTECTION AGAINST SUNBURN AND ENHANCES
EXPRESSION OF ANTIOXIDANT ENZYMES IN THE SKIN.
The inability to tan properly after sun exposure strongly correlates with increased
incidence of skin cancer. The melanocortin 1 receptor (MC1R) is a transmembrane Gscoupled cell surface receptor found on epidermal melanocytes that transmits pro-survival
and pro-differentiation signals mediated by the second messenger cAMP. Humans
carrying loss-of-function polymorphisms in MC1R signaling exhibit higher incidences of
skin cancers including melanoma.
This study focused on the physiologic effects of topical application of forskolin, an
adenylate cyclase activator, in extension (Mc1re/e) K14-SCF animals, which model the fairskinned UV-sensitive human. Twice daily application of the drug promoted accelerated
pigmentation, increased skin darkening due to epidermal deposition of melanin pigment,
and induced epidermal melanin, which protected the skin against UV injury as judged by
“minimal erythematous dose” (MED).
Moreover, MC1R signaling regulated the
expression of antioxidant enzymes at the transcriptional level. The human melanoma cell
line A375, known to harbor a loss-of-function signaling mutation in MC1R, was used to
determine effects of cAMP stimulation on the expression of antioxidant enzymes. We
observed increases in expression of genes that control the biosynthesis and regulation of
glutathione including the transcription factor nuclear factor (erythroid-derived 2)-like 2
(Nrf2), glutathione peroxidase, GPX, and glutathione reductase GSR. In addition, there is
an increase in manganese superoxide dismutase (MnSOD) at the protein level. There was
accumulation of MnSOD in the mitochondria after pharmacologic induction of cAMP with
forskolin. Addition of the oxidative agent H2O2 enhanced the expression of MnSOD at the
protein level as early as one hour after MC1R stimulation. Oxygen consumption rate on
mitochondria was measured using Seahorse analysis; pharmacologic activation of
MC1R/cAMP signaling did not affect mitochondrial metabolism. In addition, topical
application of a crude extract of Solidago inhibited UV-induced inflammation in K14-SCF
mice. Several UV-induced cytokines, including TNF-α, were down-regulated at the
transcriptional level after topical application of Solidago extract.
Together, these results indicate that MC1R signaling protects melanocytes from
UV damage by regulating antioxidant enzyme expression and suggest that pharmacologic
cAMP induction may be a useful preventive mechanism against UV-mediated skin
sunburn and oxidative injury.
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CHAPTER 1
INTRODUCTION
THE SKIN
The skin is the largest organ of the human body with an average area of 1.5 square meters
and it consists of 16% of total body mass. The skin provides physical protection to the
body from environmental, chemical and microbiologic treats. The skin thickness varies
around the body with a range of 1.0 mm in the eyelids and 4 mm in the ball of the foot
(Stucker, Struk et al. 2002). Epithelial, mesenchymal, granular, and neurovascular
components come together to compose the skin. Once it is fully developed, there are two
main layers: the epidermis and the dermis.
THE EPIDERMIS
The epidermis consists of mainly keratinocytes and it is the outmost layer of the skin. The
epidermis can be as thin as 0.1mm and it is characterized by several functional layers of
differentiated keratinocytes (Fig. 1-1). The epidermis is a self-renewing tissue; there is
constant division of keratinocyte stem cells in the stratum basale to move from the basal
layer to form nascent epidermal keratinocytes. These cells accumulate keratin, melanin
pigment and form tight junctions with each other. The outermost layer of the epidermis
consists of terminal differentiated corneocytes that are dead, yet intact cells that are
essential to create the protective physiochemical barrier of the epidermis through tightlinkages (Goodman, Miller et al. 2002).
MELANOCYTES
The skin is organized into “epidermal melanin units” wherein many keratinocytes interact
with one melanocyte (Fig 1-1). Melanocytes are the second most common cell type in the
epidermis (Barker, Dixon et al. 1995). Melanocytes are derived from neural crest cells that
1

have migratory characteristics together with peripheral and enteric neurons that migrate
to specific locations during embryonic development. These cells are called melanoblast
cells, which are un-pigmented and undifferentiated precursors of melanocytes that commit
a dorsal-ventral migration to its final location in the body. Melanoblast differentiate to
melanocytes once established in the basal layer of the epidermis. However, melanocytes
are also found in the inner ear, the iris and behind the retina. Once located in the skin,
melanocytes synthetize melanin in melanosomes. The melanosomes are vesicles
responsible for the storage and transport of melanin to keratinocytes upon exposure to
solar radiation. Keratinocytes receive melanin pigments from melanosomes (Easty, Patel
et al. 1988, Lowings, Yavuzer et al. 1992) providing a barrier against accumulation of
damaging levels UV radiation.
THE DERMIS
The dermis is located directly below the epidermis and it can be as thick as 2mm. The
epidermis and the dermis are separated by a thin basement membrane. The dermis is a
supportive layer of the skin with most dermal cells being derived from mesoderm. The
most common feature of the dermis is the presence of hair follicles among other
components of cutaneous structures including nerves, blood vessels, sebaceous glands
and sweat glands. The presence of immune cells in the dermis contributes to the immune
responses, and fibroblast cells participate in the formation of the extracellular matrix and
collagen.

2

Figure 1-1. Schematic representation of epidermal differentiation.
The epidermal unit shows the presence of melanocytes at the basal membrane. The
keratinocytes are located around the melanocytes and start to differentiate from the
stratum basale. There are three differentiation stages stratum spinosum, granulosum
and lucidum. Each layer is characterized by the induction and accumulation of different
skin markers such as keratins, cornifin, filaggrin among others while the cells are
differentiated to the surface. The corneum layer is composed of dead that serve as
the outer layer of the skin.
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ULTRAVIOLET (UV) AND SOLAR RADIATION
Due to its anatomic location at the external boundary of the body, the skin is exposed to
a variety of environmental factors such as UV radiation that derives naturally from the sun.
UV radiation is composed of UVA, UVB and UVC components based on photon
wavelength. UVA has the longest wavelengths (315-400 nm), UVB mid-range in the
spectrum (290-320 nm) and UVC has the shortest wavelengths (100-280 nm). Ambient
sunlight exposure is composed primarily of UVA (90-95%) and UVB (5-10%) energy, with
most solar UVC absorbed by the ozone layer (Fig. 1-2). UV radiation is an environmental
factor that induces skin pathologies, including erythema (Wenczl, Pool et al. 1997, AmaroOrtiz, Vanover et al. 2013, D'Orazio, Jarrett et al. 2013), inflammation (Rees 2004), aging
effects (Dalziel 1991), sunburn (Autier and Dore 1998, Mallet, Kypriotou et al. 2013) and
cancer. Unprotected exposure to solar radiation is very common and this leads to
deleterious cutaneous effects.
UVA and UVB spectra penetrate the skin differently. Variations in skin thickness and the
presence of melanin influence absorption of UV light. Epidermal melanin is able to transmit
and reflect UV emissions of less than 300 nm (Anderson and Parrish 1981) which explains
why UVA penetrates the skin more deeply than UVB despite UVA having a lower energy
profile to UVB. Similarly to melanin, other molecules like urocanic acid and the amino acids
tryptophan and tyrosine can absorb lower UV wavelength. On the other hand, the dermis
seems to have more transmittance and reflectance for longer wavelength such as the one
emitted by UVA. Dermal scattering is higher at lower wavelength allowing UVA-visibleinfrared spectrum wavelengths to penetrate the dermis (Anderson and Parrish 1981).
Other components of the dermis such as hemoglobin, bilirubin and beta-carotene are
major absorbents of visible radiation compared to melanin in which the absorption of
visible spectrum is negligible (Anderson and Parrish 1981, Parrish, Zaynoun et al. 1981).
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Reproduced with permission from Amaro-Ortiz A., Yan B., D'Orazio J.A. Molecules.
2014; 19(5):6202-6219.

Figure 1-2. UV exposure of the skin.
UV radiation in ambient sunlight is composed primarily of UVA and UVB energy. The
ozone absorbs most UVC; therefore, although it is highly bioactive, terrestrial
organisms are not exposed to significant levels of UVC. UVB can cause direct damage
to DNA and reach the epidermis. UVA can penetrate the dermis and increases levels
of ROS that indirectly induce DNA mutagenesis. The outcomes of both, UVA and UVB,
in the skin are listed.
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UVB is a well-characterized mutagen and inducer of skin cancers (Barker, Dixon et al.
1995, Darwiche, Bazzi et al. 2005, Ahsan, Reagan-Shaw et al. 2007, Grant 2008), but
recent studies have implicated an increasing role for UVA as a carcinogen (Paunel, Dejam
et al. 2005, Venditti, Bruge et al. 2011, Akhalaya, Maksimov et al. 2014) likely through its
pro-oxidative effects and possibly through other mechanisms such as telomere shortening
(Yin and Jiang 2013). In addition, UVA is less able to induce melanin production compared
to UVB, leaving the skin less able to protect itself against further UV insult (Atillasoy,
Seykora et al. 1998, Grant 2008, Wendt, Schanab et al. 2012, Flament, Bazin et al. 2013,
Yin and Jiang 2013). Increasing attention is being paid to the potential impact of UVA
radiation to areas of the body rarely exposed to natural UV, including the vulva and oral
mucosa, even focusing on differential cellular repair and apoptosis depending on anatomic
site (Breger, Baeva et al. 2013). Much of solar UV energy is absorbed by stratospheric
ozone, and the gradual depletion of stratospheric ozone over the last several decades has
resulted in higher levels of solar UV radiation that strikes the surface of the Earth (Norval,
Lucas et al. 2011). Increased ambient UV radiation from global climate change may be
an important factor to explain the increasing prevalence of melanoma and skin cancer
over the last several decades (Armstrong and Kricker 2001, Diffey 2004, Garbe and Leiter
2009, Rigel, Russak et al. 2010). Both direct and indirect DNA changes interfere with
transcription and replication, and render skin cells susceptible to mutagenesis.

UV

radiation induces a variety of free radical and oxidative molecules, which because of their
chemical reactivity alter the molecular structure and damage lipids, proteins and nucleic
acids (Chedekel and Zeise 1988).
UV-INDUCED DIRECT DNA DAMAGE
UV light has direct effects on DNA bases. The bases most susceptible to UV injury are
pyrimidines. The rates of UV signature lesions include two third cyclobutane pyrimidine

6

dimers (CPD) and one third 6-4 pyrimidine photoproducts (6-4PP) caused by UV (Roza,
van der Wulp et al. 1988, Estil, Olsen et al. 1997). CPD are formed when there is a base
substitution of a cytosine  thymine at a di-pyrimidine site. On the other hand, 6-4PP are
formed when two adjacent pyrimidines undergo photochemical reaction at the 6th and 4th
position of the pyrimidine residues forming a novel 5-6 double bond with the exocyclic
moiety of an adjacent 3' pyrimidine (Johns and Butler 1964, Sarasin 1999). The shift of
the helical distortion in the backbone of DNA caused by 6-4PP blocks DNA replication.
Both of these lesions distort the double helix and can lead to mutation. An individual skin
cell may accumulate up to 100,000 such lesions from one day’s worth of sun exposure
(Hoeijmakers 2009). These UV lesions if not repaired can lead mutagenesis. There are
mechanisms of DNA repair available for the removal of these lesions.
MECHANISM OF DNA DAMAGE REPAIR
The nucleotide excision repair (NER) pathway is the main mechanism for the repair of
CPD and 6-4PP. The NER pathway involves two types of repair, Transcription Coupled
(TCR) and Global Genome Repair (GCR) (Gillet and Scharer 2006) that only differ in their
damage recognition complex. Deficiency in any of the enzymes involved in NER leads to
Xeroderma Pigmentosum (XP), a clinical condition characterized by chronic and
excessive UV sensitivity. Many of the enzymes involved in this pathway have been named
after this condition. TCR involves RNA polymerase which stalls at a lesion in the DNA
template of actively transcribed genes. GGR is not dependent on transcription but senses
damage by the XPC-HHR23B complex that recognizes distortions in the DNA helix. After
damage is found, there is recruitment of other NER factors like XPE. XPA unwinds the
DNA followed by RPA that stabilized the DNA for the recruitment of XPB and XPD. XPG
and XPF promote excision of the damaged oligonucleotide and DNA polymerase
promotes DNA synthesis with a DNA ligase finalizing the repair process.
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The NER pathway may fail to repair UV-damage DNA. In those cases, the translesion
DNA synthesis (TLS) pathway is the cellular mechanism (DNA damage tolerance) in
response to DNA lesions caused during replication. This pathway includes three
polymerases η, ζ and REV1 that repairs DNA in an error-free (mutation avoiding) or errorprone (mutation generating) mechanism (Goodman, Miller et al. 2002, Tsaalbi-Shtylik,
Verspuy et al. 2009). During replication via an error-free mechanism, pol η uses the undamaged strand as a template to prevent mutation while REV1 creates a deletion by bypassing the damaged region during replication (Tsaalbi-Shtylik, Verspuy et al. 2009).
Other types of UV lesions are found on C-phosphate-G (CpG) sites such as methylation
of cytosine, 5mC (Ikehata, Kumagai et al. 2013). This mutation is common in the tumor
suppressor gene p53 (van Kranen, de Gruijl et al. 1995, Cui, Widlund et al. 2007).
UV-INDUCED INDIRECT DNA DAMAGE
UV radiation also damages cellular macromolecules indirectly, through production of
oxidative free radicals (Meyskens, Farmer et al. 2001). Several DNA modifications can
result from oxidative injury, including 7, 8-dihydro-8-oxoguanine (8-OHdG), which
promotes mutagenesis (specifically GC-TA transversion mutations) (Schulz, Mahler et al.
2000). UVA-induced ROS in the skin causes oxidation at the eighth position of guanine
producing 8-OhdG (Nishimura 2002, Kunisada, Sakumi et al. 2005). This DNA product, if
not repaired, will pair with an adenine instead of cytosine. Then, in the next step of
replication, the adenine will pair with a thymine inducing a mutation. Cellular maintenance
pathways exist to inactivate oxidative species as well as to repair the DNA damage these
species may cause.
MECHANISM OF DNA DAMAGE REPAIR
The base excision repair pathway (BER) is the main molecular mechanism by which cells
reverse free radical damage in DNA to avoid oxidative mutagenesis (Wyatt, Allan et al.
8

1999, Liu, Prasad et al. 2007). This pathway is initiated by lesion-specific glycosylases
that scan DNA for specific alterations including deaminated, alkylated or oxidized bases.
The glycosylase known to remove 8-OhdG is called 8-oxoguanine glycosylase, OGG.
OGG has been studied as a key DNA repair enzyme after UV- induced DNA oxidation
(Kadekaro, Chen et al. 2012). The glycosylase cleaves the N-glycosidic bond that
connects the base to the sugar, creating an abasic site (AP site). The generation of the
AP site recruits an AP endonuclease to hydrolyze the phosphodiester bond while the
glycosylase cleave the 3’ AP-Site. The residues that are formed are processed by
deoxyribose phosphodiesterase that removes the residual deoxyribose phosphate unit to
facilitate DNA synthesis with a DNA polymerase and a DNA ligase seals the strand (Wyatt,
Allan et al. 1999).
MELANIN
UV radiation can directly damage the skin. Melanin deposited in keratinocytes can
efficiently block the penetration of UV radiation in the skin (Hollis and Scheibner 1988). A
critical mediator of UV sensitivity and skin cancer risk is skin complexion, which is
determined primary by the amount and type of melanin present in the epidermis. Melanin
is derived from the amino acid tyrosine. Melanin is a large bio-aggregate of pigmented
chemical species (Fig. 1-3). Tyrosine is converted through various steps to melanin
(Jimbow, Alena et al. 1992, Fuller, Drake et al. 2000). Tyrosinase is the rate-limiting
biosynthetic enzyme in the melanogenesis pathway, as it catalyzes the first two steps of
melanin synthesis (conversion of tyrosine to DOPA and then to DOPAquinone). There
are two major “mature” forms of melanin known as eumelanin and pheomelanin
(Wakamatsu, Kavanagh et al. 2006, Ito and Wakamatsu 2011). The synthesis of melanin
occurs by successive oxidation and cyclization steps (Kim, Song et al. 2010, Kim 2014,
Kim, Baek et al. 2015).

9

Figure 1-3. The synthesis of melanin.
There are two forms of melanin: dark/black eumelanin and light/red pheomelanin. Both
eumelanin and pheumelanin are derived from the amino acid tyrosine. Tyrosinase
catalyzes the rate limiting reaction from the synthesis of melanin. The incorporation of
cysteine in the biosynthesis of melanin leads to the light/red color of pheomelanin.
There are other enzymes that trigger the synthesis of dark/black eumelanin (Tyrp1,
Tyrp2, tautomerase). The expression of mutated Tyrosinase has a phenotype of
albinism.
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Eumelanin protects against UV exposure by interfering with UV entry into the deeper,
sensitive layers of the skin. Eumelanin is a dark brown/black pigment in contrast to
pheomelanin, which is a light red pigment less able to block UV. Pheomelanin is a sulfur
containing pigment that may actually potentiates UV injury in the skin. Pheomelanin
contributes to free radical formation and oxidative cellular damage (Mitra, Luo et al. 2012).
In addition, the structure of pheomelanin is photosensitive and increases pro-oxidant
levels in the skin (Salopek, Yamada et al. 1991). Therefore, individuals with high levels of
pheomelanin and low levels of eumelanin in the skin are UV sensitive and are at a greater
risk for developing skin cancers including melanoma (Wakamatsu, Kavanagh et al. 2006).
If the skin is continually stimulated for melanin production, the melanin will stay and deposit
in keratinocytes until the UV exposure is removed. Dark pigmented skin is protected
against formation of CPD (Yamaguchi, Coelho et al. 2008), photoproducts (de LimaBessa, Armelini et al. 2008), and a decrease in oxidative stress (Jenkins and Grossman
2013).
Various inhered and environmental factors control the ratio of eumelanin-to-pheomelanin
in total amount of melanin. When melanocytic cytoplasmic cAMP levels are high,
eumelanin production is favored compared to lower levels of cAMP that induce the
synthesis of pheomelanin.

Individuals can be categorized by phenotype of skin

complexion using the Fitzpatrick Scale. This scale ranges from very fair skin (e. g.
Northern Europeans type I) to very dark (e. g. for Aboriginal African type VI). Risk of
sunburn is linked to not only UV dose and intensity of UV exposure, but also by hereditary
factors that influence cutaneous response to UV radiation.

Many factors determine

melanocytic response to UV. Skin cancer risk is inversely proportional to phenotype scale
in which a type 1 skin complexion has a higher risk than type VI.
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SKIN CANCER
Skin cancer is the most diagnosed cancer in United States and it is caused by an
uncontrolled growth of genetically mutated skin cells. There are keratinocyte and
melanocyte malignancies that, together, are by far the most numerous cancers diagnosed
today (Lo and Fisher 2014). Skin pigmentation is one of the most important determinants
of UV sensitivity. Melanoma, the most deadly form of skin cancer, occurs roughly twenty
times more frequently in light-skinned persons compared to their dark-skinned (Tucker
2009, Psaty, Scope et al. 2010, Udayakumar, Mahato et al. 2010). Because of low innate
levels of eumelanin pigment in the epidermis, fair-skinned individuals are much more
prone to acute and chronic effects of UV radiation including sunburns, photo-aging and
skin cancers (Conley and Pack 1963, Evans, Kopf et al. 1988, Gibson, Donald et al. 1997).
Besides innate skin pigmentation, the ability to tan after sun exposure is also another
important determinant of UV sensitivity (Suzuki, Im et al. 1999, Abdel-Malek, Knittel et al.
2008, Munoz-Hidalgo, Lopez-Gines et al. 2014).
NON MELANONOMA SKIN CANCER
Non-melanoma skin cancer (NMSC) develops from abnormal keratinocytes. These types
of cancer include basal cell (BCC) or squamous cell carcinomas (SCC), which are
generally diagnosed early and are treated surgically. Actinic keratosis (AK) was identified
as an early stage of NMSC and if left untreated, up to ten percent of cases of AK can
develop into SCC. There is an estimate increase of 200 percent in the diagnosis of SCC
in USA since 1990. This type of cancer is generated in outer layers of the epidermis,
starting in a localized area in the skin and caused by long-term exposure to solar radiation.
BCC accounts for 80% of NMSC cases and almost never metastasizes (Gupta, Daigle et
al. 2014). BCC is generated from deeper areas of the epidermis and has been
characterized for its slow growth. BCC is caused after long-term exposure to the sun or
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occasional intense episodes that lead to sunburn. There are different therapeutic options
after being diagnosed with NMSC. Electro-desiccation of a tumor has cure rates of 95%.
Other procedures include tissue removal by surgery, cryosurgery, laser surgery, topical
medication, radiation, and among others.
MELANOMA
Melanoma accounts for almost 10,000 deaths each year in the US alone, despite
representing a small fraction of the total number of skin malignancies (Bristow, Casil et al.
2013). Melanoma, derived from melanocytes, is usually curable at early stages. However,
once it advances and invades other tissues, it is generally resistant to cancer treatments.
It is prone to spreading throughout the body from its site of origin (most frequent in the
epidermis). For a variety of reasons, the prevalence of melanoma has been steadily
increasing in Western countries for decades. Whereas only one in approximately 1,500
Americans were diagnosed with melanoma in his/her lifetime in the 1930’s, today that
number has increased to roughly one in sixty people. Risk factors include family history
of skin cancer, weakened immune response, moles, and sun exposure. There are two
types of moles: benign moles and atypical moles, also known as dysplastic nevi. Even
without family history, individuals with a high number of moles face a high risk of
developing melanoma.
MELANOMA PROGRESSION
Most melanomas are derived from moles (nevi). At the molecular level, dysplastic nevi
have an 80% frequency in mutations of BRAF, an oncogene that controls melanocytes
cell growth (Fig. 1-4). Specifically, BRAFV600E leads to an increase in cell proliferation
followed by cell senescence triggered by CDK4 activation, a regulator of cell cycle
(Bertolotto 2013, Munoz-Hidalgo, Lopez-Gines et al. 2014). CDK4 loss leads to a radial
phase growth in the progression of melanoma and, PTEN mutation leads to the activation
13

Reproduced with permission from Miller, A. J. and M. C. Mihm, Jr. (2006). N Engl J
Med 355(1): 51-65. Copyright Massachusetts Medical Society

Figure 1-4. The progression of skin cancer.
Benign nevi show a BRAF mutation and activation of the MAPK signaling pathway.
Atypical dysplastic nevi show loss of cyclin dependent kinase inhibitor (CDKN2A) and
PTEN leading to an impaired cell cycle control. The growth phase of melanoma is
characterized by up-regulation of cell adhesion signaling pathway. Other genes that
loss regulated signaling are E-cadherin, N-cadherin, MMP-2 and TRPM1 a
melanocyte-specific gene melastatin 1 (Miller and Mihm 2006).
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of PI3K-AKT pathway that favors early stages of invasive melanoma. The activation of Ecadherin and WNT5A lead to the invasion into the dermis, the vertical growth phase. At
this point, the aggressiveness of the cells lead to metastatic effects due to the loss of
regulation of cellular proliferation, cell survival and apoptosis pathways.
Current therapeutic treatment for patients with melanoma is an initial procedure involving
the surgical removal of the localized tumors. However, for specific cases, a physician
might recommend a round of chemotherapeutic drugs targeting different oncogenes such
as BRAF and MEK. The use of vemurafenib (Grimaldi, Cassidy et al. 2014), a BRAF
inhibitor and trametinib a MEK inhibitor (Yajima, Kumasaka et al. 2012) are increasingly
used in treatment of melanoma. Usually, these treatments are recommended for advance
stages of melanoma leading to a better prognosis for survival. However, only a percentage
of melanoma cases have mutations in BRAF, restricting therapeutic options for patients.
Melanoma occurs roughly twenty times more frequently in light-skinned persons
compared to dark-skinned individuals (Aubin, Humbey et al. 2001). The incidence of
melanoma in the United States has increased dramatically over the last several decades,
particularly among fair-skinned individuals. Strong molecular and epidemiologic evidence
supports the hypothesis that UV radiation is a major mutagenic environmental carcinogen
responsible for melanoma (Gallagher, McLean et al. 1990, Kraemer, Lee et al. 1994,
Wang, Yu et al. 2009, Pleasance, Cheetham et al. 2010, Parkin, Mesher et al. 2011,
Wang, Smith et al. 2014). The role of UVA in melanoma formation is suggested by the
observation of rising melanoma incidence over the last several decades and sunscreen
use in the 1980s when only UVB-blocking sunscreens were used. UV exposure is thought
to be a causal factor in the majority of melanoma cases. Clearly the more UV a person is
exposed to (particularly strong intermittent doses such as those that cause sunburns), the
higher his/her risk of melanoma.
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Melanoma risk can be determine by the amount of sunlight exposure, occupational and
recreational outdoor activities, amount of clothing/sun protection worn as well as proximity
to the equator and altitude. However, a contributor factor for melanoma of increasing
importance is the use of artificial UV (Dore and Chignol 2012). Proliferation of tanning
beds use has played a role in this increase (Fisher and James 2010, Weinstock and Fisher
2010). There are more than one million people in United States of America using tanning
beds per day (Spencer and Amonette 1998, Grimaldi, Cassidy et al. 2014). Several
studies have estimated that indoor tanning bed use before the age of thirty-five, for
example, increases lifetime risk of melanoma by as much as 75% (Schulman and Fisher
2009, Karagas, Zens et al. 2014).

Even more than chronic lifetime UV exposure,

melanoma risk seems particularly linked with sunburns (Pfahlberg, Kolmel et al. 2001),
especially those early in life (Lew, Sober et al. 1983, Autier, Dore et al. 1998).
OXIDATIVE INJURY
The role of oxidative injury in the skin has been studied (Bickers and Athar 2006,
Svobodova, Zdarilova et al. 2007, Piao, Ahn et al. 2014). Long exposure to UV radiation
increases risk of keratinocytes malignancies (Potter, Gohde et al. 2000). Consequently,
UVA has been found to have a role in the increased production of ROS (reactive oxygen
species) in the skin. (Nataraj, Black et al. 1996) ROS are oxygen-like radical anions and
molecules that due to their unstable electrons are very reactive. ROS are identified as
superoxide radical O.-2 , hydroxyl radical OH. and hydrogen peroxide, H2O2. Similar to ROS,
reactive nitrogen species (RNS) such as nitric oxide (NO) and peroxynitrite (OONO-)
increase the generation of oxidative stress. Oxidative stress is an imbalance in the
generation of ROS and the antioxidant enzymes in the cells. Figure 1-5 shows a simplified
scheme of the location of these species in the cell. Antioxidant enzymes are the main
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Reproduced with permission from Amaro-Ortiz A., Yan B., D'Orazio J.A. Molecules.
2014; 19(5):6202-6219.

Figure 1-5. Antioxidant enzymes and oxidative stress.
UV induces a variety of free radical and oxidative molecules, which because of their
chemical reactivity damage lipids, proteins and nucleic acids. Antioxidant enzymes
mediate the removal of ROS, with different enzymes functioning in specific
compartments (e.g. MnSOD localized to mitochondria). If not removed, ROS may
react with DNA and other cell signal proteins, impairing their function. GSH,
Glutathione. ECSOD, Extracellular Superoxide dismutase. Cu/Zn SOD, copper/zinc
superoxide dismutase. MnSOD, Manganese Superoxide dismutase.
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regulators of the levels of ROS, acting to minimize ROS-mediated formation of DNA and
proteins adducts and impairment of cellular function.
ROS are produced by cells during normal metabolic activities such as mitochondrial
oxidative phosphorylation. Without inactivation, ROS can damage macromolecules
including lipids, proteins and DNA. UV, particularly longer-wavelength UVA, is a wellknown inducer of ROS, and UV-induced oxidative stress may be an important contributive
factor for melanoma (Bossi, Gartsbein et al. 2008, Afanas'ev 2010, Choi, Uehara et al.
2012).

ROS can inappropriately activate signaling pathways, interfere with genome

maintenance, and affect apoptosis. Numerous studies have tested the effects of solar
radiation and oxidative stress on the skin (Hu 2005, Poljsak and Dahmane 2012, Gabe,
Osanai et al. 2014), and oxidative stress has been linked to age-related loss of skin
elasticity (Langton, Sherratt et al. 2010, Mahmood, Akhtar et al. 2011, Naylor, Watson et
al. 2011), defective cellular signaling (Prunier, Masson-Genteuil et al. 2012) and photoaging (Stohs 1995, Lee, Cho et al. 2012).
ANTIOXIDANT ENZYME EXPRESSION
The term oxidative stress combines the excess of ROS with lower levels of antioxidant
enzymes. The major antioxidant in most types of cell is glutathione (GSH). The role of
GSH is to facilitate the depletion of H2O2 to H2O.

GSH is oxidized by glutathione

peroxidase, GPX. GPX takes GSH and converts it to GSSG in order to reduce H2O2 to
H2O. Then, GSSG is recycled by glutathione reductase, GSR. GSR together with the cofactor NADPH produces GSH and NAD(P)+. Another antioxidant enzyme that controls the
levels of H2O2 is catalase. Catalase is a nuclear-encoded protein that is located in
peroxisomes and its levels increase after UV exposure (Schallreuter, Moore et al. 1999)
in melanocytes (Song, Mosby et al. 2009, Kadekaro, Chen et al. 2012). When there is
depletion of GSH due to an increase in the levels of ROS, there is activation of the
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transcription factor Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) (Fig. 1-6) (Kokot,
Metze et al. 2009). Nrf2 regulates the expression of glutamate cysteine ligase, GCLC, the
enzyme that controls the catalytic limiting step for the synthesis of GSH. GCLC is known
as γ-glutamyl cysteine synthase (Gipp, Chang et al. 1992). Therefore, there is recovery in
the expression of GSH in a functional cell. Also, Nrf2 is involved in the regulation of GSR
and glutathione-S-transferase, GSTA. GSTA is involved in the reduction of ROS-induced
oxidized proteins (Kokot, Metze et al. 2009). The concentration of GSH decreases with
skin tumor progression (Engin 1976, Bickers and Athar 2006). Levels of SOD are
decreased in basal cell carcinoma (Nakagami, Inamura et al. 1991). As expected, several
studies have found that there is an increase in the oxidative state of skin cancer cell lines
(Engin 1976, Nakagami, Inamura et al. 1991, Liebler and Burr 2000, Schallreuter and
Wood 2001). Taken together, the regulation of oxidative stress is the key to decreasing
the burden of UVA-induced oxidative stress.
SUPEROXIDE DISMUTASE
Superoxide radical ( O.-2 ) is generated by photoexcitation of triplet oxygen � 3O2 � that by

1
transferring an electron to an intermediate singlet oxygen specie � O2 � induces the

formation of O.-2 (Mayeda and Bard 1974). Specific antioxidant enzymes that decrease
levels of O.-2 radicals are called superoxide dismutases (SOD). They are found among

different locations in the cells but their common role is the removal of superoxide radicals
from the cell. Cu/ZnSOD is found in the cytoplasm and mitochondrial membrane. ECSOD
is found anchored in the plasma membrane and its role is to regulate O.-2 radicals produced
during lipid peroxidation such as 4-hydroxy-nonenal and malondialdehyde. In addition,
there is endogenous production of O.-2 by the electron transport chain in the mitochondria.
Levels of O.-2 in the mitochondria are depleted by MnSOD converting O.-2 to H2O2 for further
conversion to H2O by GPX or catalase. Polymorphisms in SODs are associated with
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Figure 1-6. The signaling pathway of Nrf2 and NfκB after cell injury.
Endogenous and exogenous activators induce the release of Nrf2 from its inhibitor
keap1 leading to keap1 degradation. Nrf2 translocates to the nucleus and binds to
antioxidant response element (ARE) promoting the expression of different genes.
Some of these genes are regulators of glutathione synthesis, the transporters MRP 1,
3, & 4 among other antioxidant genes. On the other hand, IκBα inhibits NF-κB in the
cytoplasm. The phosphorylation of IκBα leads to its degradation and further
phosphorylation of NF-κB. Nf-κB translocates to the nucleus binding to the κB site in
DNA promoting the regulation of apoptotic genes, cell cycle regulators inflammatory
signaling and immune responses.
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cardiovascular and neurodegenerative disorders (Berneburg, Gremmel et al. 2005,
Boutte, Woltjer et al. 2006, Zhang, Yang et al. 2009, Lai, Xu et al. 2013). Cu/ZnSOD and
ECSOD are inhibited by H2O2; MnSOD is inactivated by peroxynitrite. The gene
expression of SOD is regulated by nuclear factor kappa B, NF-κB (Dhar, Xu et al. 2010)
(Fig. 1-6). NF-κB is inhibited in the cytoplasm by inhibitor kappa beta, IKβ (Dhar and St
Clair 2012). NF-κB is activated by UV-mediated MAP Kinase pathway that phosphorylates
IKβ. This inhibits IKβ and releases NF-κB to translocate to the nucleus and together with
a co-regulator, activates the expression of many gene-encoding receptors, cytokines and
antioxidant enzymes such as SOD. IKβ inhibits NF-κB translocation to the nucleus.
Interestingly, the receptor of 1α,25-Dihydroxyvitamin D3, the active form of vitamin D,
interacts with IKβ inhibiting NF-κB activity (Chen, Zhang et al. 2013). UV induces the
generation of 1α,25-Dihydroxyvitamin D3 and by activating its receptor, stabilized IKβ and
induces an attenuation of NF-κB nuclear translocation. Nonetheless, there is positive
feedback for the degradation of IKβ upon the presence of endogenous or exogenous
cellular stress activators. The kinetics for expression of several antioxidant enzymes at
the transcriptional level usually is within hours (Lundqvist, Yde et al. 2014).
SKIN AGING AND ANTIOXIDANT DEFENSES
Because it triggers cellular damage pathways, oxidative stress activates cellular
senescence, which is thought to directly lead to photo-aging (Velarde, Flynn et al. 2012,
Yun, Kwon et al. 2012, Sakura, Chiba et al. 2013). Cellular senescence is associated with
a reduced capacity to divide and proliferate, sometimes in conjunction with the shortening
of telomeres (Kashino, Kodama et al. 2003, Yokoo, Furumoto et al. 2004, Davis, Wyllie et
al. 2007, Makrantonaki and Zouboulis 2007). Yokoo et al. found that exposing cells to a
pro-oxidant agent (H2O2) impaired telomerase function which eventually resulted in
telomere shortening, decreased proliferation, and cellular enlargement (Yokoo, Furumoto
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et al. 2004). Wrinkling of the skin is one of the most overt signs of photo-aging, and UV
exposure can induce wrinkling over time (Raschke, Koop et al. 2004, Cornacchione,
Sadick et al. 2007, Felippi, Oliveira et al. 2012, Kong, Shi et al. 2013). Though the
molecular mechanism(s) of wrinkling are likely to be complex, UV exposure may reduce
elastic properties of the skin to alter the three-dimensional structure of elastic fibers
(Imokawa 2009).
There is a lot of interest in the study of antioxidant enzyme depletion leading to skin aging.
The constant exposure to UV, allows the skin to show early symptoms of aging such as
wrinkles, dryness and stiffness. Several natural products may reduce UV-induced
oxidative damage. One mechanism of action of these natural agents is in the activation of
the ascorbic acid pathway and reducing the levels of lipid peroxidation (Villacorta, Zhang
et al. 2007). Another mechanism of antioxidant control is the activation of the Nrf2 pathway
that has been implicated as a beneficial effect of resveratrol (Soeur, Eilstein et al. 2015).
The use of resveratrol in human keratinocyte induces accumulation of cellular glutathione.
Similar studies in mice showed that the main component in licorice root, 18B-glycyrrhetinic
acid, induces expression of SOD and GPX (Kong, Shi et al. 2013). The use of natural
flavonoids showed a beneficial effect against UV-induced inflammation (Masnec, Kotrulja
et al. 2010, Nichols and Katiyar 2010). For example, flavonoids such as solidago induced
anti-inflammatory signaling in reticulo-endothelial systems (Apati, Houghton et al. 2006,
Wu, Takahashi et al. 2007, Lutz, Kulshrestha et al. 2014).
MELANOCORTIN 1 RECEPTOR (MC1R)
The MC1R is a 7-transmembrane protein located in the plasma membrane of
melanocytes. MC1R is located on chromosome 16q24.3 in human and in mouse
chromosome 8: 123,407,107-123,410,744. It is a 34.7 kilodalton transmembrane Gscoupled hormonal receptor (Smith, Box et al. 2001). The role of MC1R is to control the
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ratio of eumelanin and pheomelanin synthetized in the skin and hair of many species. In
mice, MC1R deficiency on C57BL/6J mice causes red/pink blonde hair compared to a
dark/black heavy pigmented complexion in wild-type state. The over-expression of MC1R
causes a heavily melanized epidermis that might lead to deficiency in vitamin D production
that requires UV-exposure for its biosynthesis (Slominski, Kim et al. 2013). Polymorphisms
of MC1R were selected in world populations as people moved from the equator to
geographical areas that UV is less rich to prevent 1α,25-Dihydroxyvitamin D3 (vitamin D)
deficiency and rickets. For example, in Northern America, loss of function of MC1R is
common. The most common MC1R polymorphism are known as red hair color (RHC)
mutations Asp294His (D294H), Arg151Cys (R151C) and Arg160Trp (R160W) (Davies,
Randerson-Moor et al. 2012, Pellegrini, Fargnoli et al. 2012). These mutations increase
the incidence risk for sunburn and an increase prevalence of melanoma by four fold.
THE MC1R PATHWAY
The endogenous agonist ligand of MC1R is α-melanocyte stimulating hormone, α-MSH.
The binding of α-MSH to MC1R leads to the activation adenylate cyclase (AC) (Rouzaud,
Kadekaro et al. 2005). Then, AC converts a molecule of ATP to cAMP working as a
second messenger protein with many roles in cellular signaling. This leads to the activation
of the cAMP respond element-binding protein (CREB) to translocate to the nucleus
inducing microphthalmia inducer transcription factor, MITF. This is a critical regulator for
melanocyte differentiation and melanin production (Fig. 1-7).
THE TRANSCRIPTION FACTOR MITF
MITF is a transcriptional factor that recognizes E-box and M-box sequences in the
promoter regions of target genes (Hoek, Schlegel et al. 2008). MITF regulates the
expression of Tyrosinase, and Tyrosinase related proteins that are the main regulators in
the synthesis of eumelanin. The accumulation of cAMP induces pro-differentiation and
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Modified with permission from D'Orazio, J. A., T. Nobuhisa, R. Cui, M. Arya, M. Spry,
K. Wakamatsu, V. Igras, T. Kunisada, S. R. Granter, E. K. Nishimura, S. Ito and D. E.
Fisher (2006). Nature 443(7109): 340-344 and Cui, R., H. R. Widlund, E. Feige, J. Y.
Lin, D. L. Wilensky, V. E. Igras, J. D'Orazio, C. Y. Fung, C. F. Schanbacher, S. R.
Granter and D. E. Fisher (2007). Cell 128(5): 853-864.
Figure 1-7. The adaptive tanning response.
Upon UV irradiation, the DNA damage response lead to the activation of the
expression of POMC in keratinocytes. POMC is cleaved, producing three products,
among them α-melanocyte stimulated hormone (α-MSH). Activated by its agonist αMSH, MC1R promotes cAMP second messenger generation which induces
melanocyte differentiation and survival pathways involving PKA, CREB and MITF In
this way, cAMP induces both melanin production and antioxidants that reduce cellular
ROS. cAMP, cyclic adenosine monophosphate. PKA, protein kinase A. pCREB,
phosphorylated cAMP response binding element. ROS, reactive oxygen species.
MITF, microphthalmia (Mitf) transcription factor.
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survival signaling in melanocytes in addition to high levels of MITF. Studies performed in
B16 mouse melanoma cells confirmed a link between MITF expression and melanin
production and stimulation of NADPH oxidase 4 (Nox4). Liu and colleagues showed that
APE-1 induces MITF leading to cell survival (Liu, Fu et al. 2009). Low levels of cAMP led
to lower expression of MITF and the synthesis of the oxidation-prone pheomelanin.
Waardenburg syndrome (WS) is a genetic disorder arising from the neural crest and
among its defects, there is deafness and pigmentation abnormalities. Deficiency in MITF
expression has been identified in WS (Grill, Bergsteinsdottir et al. 2013). Kim and
colleagues found that ROS induced ERK signaling increases MITF degradation (Kim, Park
et al. 2014).
THE LIGANDS OF MC1R
α-MSH is produced in keratinocytes and is a metabolite of the pro-opiomelanocortin propeptide (POMC) (Hadley and Haskell-Luevano 1999). DNA damage pathways, including
p53, induce POMC expression after UV injury. α-MSH is a small peptide with only 13
amino acids (HOOC-SYSMEHFRWGKPV-NH2) (Sahm, Olivier et al. 1994). However,
among soluble ligands of MC1R, α-MSH does not have the highest binding affinity. There
are other products that are cleaved from POMC. These ligands are β-MSH, γ-MSH, βendorphin and adrenocorticotropic hormone (ACTH) and they not only regulate weaker
levels of cAMP with MC1R but also bind to other melanocortins expressed in the skin.
There are two peptides identified that limit or inactivate MC1R signaling in the skin: agouti
signaling protein (ASIP) and β-defensin 3 (BD3). Both β-defensin and agouti inhibit α-MSH
binding MC1R by blocking its active site (Swope, Jameson et al. 2012). ASIP has higher
affinity for MC1R than α-MSH and can directly bind and down-regulate the production of
cAMP (Voisey and van Daal 2002, Ito and Wakamatsu 2011). BD3 was identified as an
antimicrobial peptide and it has higher affinity to MC1R than ASIP (Abdel-Malek and Supp
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2008, Swope, Jameson et al. 2012, Benato, Dalla Valle et al. 2013). It is important to
remember that although MC1R has a protective effect in the skin, there is tight regulation
of its activation and downstream targets. Although MC1R RHC mutations are known to
impair MC1R signaling, there are different ligands that have a role as antagonists leading
to MC1R inactivation. There is little known about the role of these antagonists but they
might be present as a regulatory aspect to limit the production of melanin only when
required. Nonetheless, MC1R is a key receptor for the regulation of adaptive pigmentation
in the epidermis and its activation and regulation in the context of whole skin is likely to be
complex.
MC1R DEFICIENCY
MC1R activates the adaptive pigmentation pathway. The phenotype of individuals lacking
MC1R show a fair-skin complexion leaving the skin to the exposure of hazardous UV
doses that could be blocked by the accumulation of more of eumelanin. This leads to DNA
damage that contributes to melanocyte mutagenesis. Several studies show a direct impact
of MC1R deficiency in the level of UV-damage products in melanocytes (Jarrett, Horrell et
al. 2014). MC1R defective melanocytes are not able to repair UV damage efficiently
leading to higher risk of mutagenesis skin-prone population. There are limited studies
about the role of MC1R in the regulation of UV-induced oxidative injury. Mitra and
colleagues reported that melanocytes with mutated MC1R lead to melanoma formation
without UV exposure by the oxidative damage caused by the expression of pheomelanin
(Mitra, Luo et al. 2012). The MC1R protein is also a major regulator of melanoma risk in
humans (Valverde, Healy et al. 1996, Rees 2000, Box, Duffy et al. 2001, Kennedy, ter
Huurne et al. 2001, Sturm 2002, Galore-Haskel, Azizi et al. 2009, Hoiom, Tuominen et al.
2009, Ibarrola-Villava, Fernandez et al. 2010, Scherer, Nalls et al. 2010, Cust, Goumas et
al. 2012, Ghiorzo, Bonelli et al. 2012), therefore I have been interested in the mechanisms
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by which MC1R signaling protects melanocytes against UV-induced oxidative stress and
antioxidant defenses.
K14-SCF TRANSGENIC MOUSE MODEL
In humans, melanocytes are localized in the stratum basale above the basal lamina of the
epidermis (Fig 1-1). The survival and migration of melanocytes is regulated by a receptor
tyrosine kinase cKIT or KIT receptor (Murakami, Matsumoto et al. 1995, Herraiz, Journe
et al. 2011, Azevedo, Horvath et al. 2013). This receptor controls melanocyte
development, migration and survival and it is activated by a stem cell factor (SCF) also
known as KIT ligand (Guo, Jie et al. 2014). The cKIT signaling pathway promotes
phosphorylation of MITF leading to its short-lived activation and further degradation
(Torres-Cabala, Wang et al. 2009). This regulates MITF expression after α-MSH signaling
activates MC1R.
The use of mice as an animal model to investigate pigment-dependent physiology in the
skin is limited because of innate differences between human skin and mouse skin.
Whereas human skin maintains melanocytes in the epidermis throughout life (imparting
melanin pigments to the epidermis), mouse skin is only transiently populated by
melanocytes in the epidermis in the neonatal period. For adult mice, their melanocytes are
located in the hair follicle at the dermis. This feature results in a fur coat color rather than
skin pigment. In addition, during postnatal development, melanocytes can be found in the
ears, tail and paws. However, these melanocytes cannot be retained due deficiency in
stem cell factor (SCF) expression leading to inactivation of cKIT receptor.
One approach to be able to utilize mice to study pigment effects (such as cAMP rescue of
melanization) is to transgenically express melanocyte growth factors (such as SCF) in the
epidermis constitutively throughout life. We had reported the use of a transgenic C57BL/6
mouse model that resembles human skin. In this model, the keratin 14 (K14) SCF
27

transgene, which is constitutively expressed in keratinocytes, retains melanocytes in the
epidermis. This model features localization of melanocytes in the epidermis and
accumulation of black/dark pigmented melanin in the skin of wild-type Mc1rE/E Tyr+/+ mice.
On the other hand, there is production of a red/light pigmented melanin in Mc1re/e Tyr+/+
mice due to deficiency in MC1R signaling. There is an albino mouse Mc1rE/E Tyrc2j/c2j mice
that signals MC1R, but it is deficient in tyrosinase expression, and it is unable to produce
melanin. Finally, the albino extension mouse is Mc1re/e Tyrc2j/c2j unable to produce melanin
and it is deficient for MC1R signaling.

This mouse model reflects three possible

phenotypes in human skin complexion.
FORSKOLIN
There are numerous options for the induction of sunless tanning response in the skin.
Among them, a natural product called forskolin has generated interest from researchers
and general public. Forskolin, identified in 1974 by a Finnish botanist named Forskal, is
a bioactive constituent of the root portion of the Coleus forskohlii (Plectrantus barbatus)
plant (Lukhoba, Simmonds et al. 2006) and it is cultivated in South East Asia that included
countries like India, Nepal, Sri Lanka, and Thailand. Scientists characterized it because
the plant from which it was derived had long been used in traditional Ayurvedic medicine
for a range of disorders and diseases. Forskolin, also known as Coleonol, has a unique
heterocyclic structure that classifies the molecule as part of the labdane diterpene family
(Fig 1-8).
The crude root forskolin extract has many components including alkaloids, phenols,
tannins and histamines (Alasbahi and Melzig 2012). The forskolin extract has been
reported to induce hypotension (De Vries, Amdahl et al. 1988, Lindgren, Crossley et al.
2011), blood thinness (Hayashi and Sudo 2009), mast cell degranulation (Cheli, Giuliano
et al. 2012) and stimulation of adenylyl cyclase (Pinto, Papa et al. 2008). Forskolin has
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Figure 1-8. The structure of forskolin.
The compound, which molecular formula is C22H34O7 and is known as forskolin, can
bind to 8 of the 9 isoforms of adenylate cyclase (AC). AC is activated by G-protein to
catalyze the conversion ATP to cAMP. Pharmacologic activation of AC using forskolin
decreases receptor agonists’ desensitization that down-regulate AC signaling
cascade..
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been study for its many beneficial physiological effects on skin conditions such as
psoriasis and eczema. Recent studies attribute positive effects to treat weight loss (Geller,
During et al. 1993, Doseyici, Mehmetoglu et al. 2014) and to alleviate symptoms
associated with painful menstrual periods (da Conceicao, de Oliveira et al. 2012).
Together with antibiotics, forskolin has been used for the treatment of urinary tract
infection (Doseyici, Mehmetoglu et al. 2014). Forskolin has been studied as a vasodilator
for cardiovascular diseases to prevent hypertension (Enomoto, Yoshihisa et al. 2011).
However, oral administration of forskolin also induces side effects such as headaches
and accelerated heart rate (Galeotti, Ghelardini et al. 2001). These effects have been
linked to an increase in bleeding episodes (Onoue and Katusic 1998).
At the molecular level, forskolin is able to bind to adenylate cyclase (AC), an enzyme
responsible for the production of the second messenger cAMP from ATP. The AC isoforms
are restricted to specific tissue (brain, liver, lung, uterus, testis and muscle) and excitable
cell types (endothelial cells) (Sunahara and Taussig 2002). There are nine isoforms of AC
and the binding of G-protein subunits regulates its activation. Forskolin is able to mimic
the G-protein and it binds at the catalytic site of AC to allow ATP access and
transformation to cAMP (Cumbay and Watts 2004). Forskolin can bind to all AC isoforms
except AC9 (Cumbay and Watts 2004). Once activated AC changes its conformation to
allow the binding of ATP. ATP is converted to cAMP which is a second messenger inducer
for a numerous of intracellular signaling pathways. There are pharmacologic drugs
available that can directly increase cAMP levels such as forskolin and rolipram, a
phosphodiesterase (PDE) inhibitor. PDE is known to mediate the degradation of cAMP.
These drugs can activate the pathway independent of MC1R status. However, a
pharmacologic formulation of forskolin is able to penetrate the skin and is efficiently
absorbed transdermally.
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FORSKOLIN-MEDIATED MELANIN RESCUE
As discussed previously, MC1R triggers the activation of adenylate cyclase for the
production of cAMP, activation of MITF, and synthesis of protective eumelanin. However,
deficiency in MC1R signaling induces low levels of cAMP and production of pheomelanin.
However, MC1R RHC mutation and inhibitors do not affect the mechanism mediated by
forskolin since forskolin is able to bypass the receptor dependent signaling (Abdel-Malek
and Supp 2008). We, together with other laboratories, have utilized forskolin as an
adenylate cyclase activator. Using our mouse model, topical administration of forskolin
induced eumelanin accumulation in the skin of K14-SCF Mc1re/e Tyr+/+ extension mice
compared with non-transgenic treated and untreated mice. After chronic stimulation of
cAMP daily for 21 days leading to accumulation of melanin, these mice showed no
changes in body weight and liver size (Spry, Vanover et al. 2009). However, there was
an increase in epidermal thickening (Scott, Christian et al. 2012). Forskolin induced
expression of the keratinocyte growth factor, leading to keratinocyte accumulation in the
epidermis.
Therefore, among its other mechanisms, forskolin-induced skin darkening is a target of
cAMP production (D'Orazio, Nobuhisa et al. 2006). Topically-applied forskolin seems to
be systemically absorbed, leading to systemic cAMP stimulation in the mice as evidenced
by darkening of skin in other sites. Previously, we reported that the most darkening of the
skin was obtained after 2 weeks of daily treatment with forskolin and persist as long at the
topical application was continued. In fair-skin individuals, unless there is constant
application of forskolin, the darkening of the skin fades away and the skin returns to its
normal shade. This means that the K14-SCF by itself does not rescue melanin production
of the skin. The mechanism of skin darkening requires stimulation of the adaptive
pigmentation pathway for the production of melanin and further deposition in
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keratinocytes. If there is pharmacologic stimulation of melanin production, we can study
the relation between the stimulation of MC1R and the expression of UV-mediated DNA
damage products after darkening of the skin. In addition, this method is useful to study
DNA repair mechanisms that can be addressed as targets for the therapeutic application
and prevention of UV-mediated skin mutagenesis.
MELANIN-INDEPENDENT EFFECTS
There are other effects mediated by forskolin that are melanin-independent. The solute
carrier family 24 member 5 (SLC24A5) is a regulator of the ratio of dark and light
pigmented melanin in the skin. Cheli and colleagues were able to show the up-regulation
of this transporter after an increase of cAMP in forskolin treated B16 mouse melanoma
cells (Cheli, Luciani et al. 2009). This regulation has an important role in melanosomes
alkalization and regulation melanin synthesis. Spindler et al. studied the role of cAMP in
the loss of keratinocytes cohesion and further blister formation in transformed
keratinocytes and neonatal mice (Spindler, Endlich et al. 2011). Forskolin together with
rolipram, prevented the loss of desmoglein, a calcium-dependent adhesion molecule,
preventing the loss of cell adhesion. Kokot and colleagues study the effect of the
MC1R/cAMP pathway in the regulation of antioxidant enzymes expression (Kokot, Metze
et al. 2009). The use of α-MSH induces Nrf2 and Nrf2-induced gene expression in human
keratinocytes. Nrf2 is a transcription factor for key antioxidant enzymes such as
glutathione and glutathione regulators. Forskolin shows the same effect as α-MSH
inducing expression of Nrf2 by increasing cAMP production and CREB binding to the
promoter region of Nrf2 (Kokot, Metze et al. 2009). Furthermore, forskolin increases the
removal of cyclobutane pyrimidine products and 6-4PP caused by UVB exposure (Jarrett,
Horrell et al. 2014). A proposed mechanism of action includes the modulation of DNA
damage repair factors such as xerodermal pigmentosum complement group A (from the
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NER pathway) as a downstream target of cAMP signaling. In addition, forskolin treatment
of human keratinocytes decreased UVB-induced apoptosis (Passeron, Namiki et al.
2009).
RATIONALE
UV exposure is one of the most important environmental health hazards, clearly causative
for age-related skin changes such as wrinkling, pigmentary changes, thinning and
carcinogenesis. Because of complex societal factors, UV exposure may actually be
increasing through increased occupational and recreational activities including indoor
tanning. There is emerging evidence implicating MC1R and cAMP signaling in regulating
antioxidant proteins.

Using keratinocytes transfected with MC1R, Henri et al. reported

lower cellular levels of ROS after pharmacologic activation MC1R/cAMP pathway and
higher levels of ROS when PKA was pharmacologically inhibited (Henri, Beaumel et al.
2012). In other work using human melanocytes, Song and colleagues found that α-MSHinduced MC1R signaling increased levels of catalase after UV exposure (Song, Mosby et
al. 2009). Finally, Kaderaro and coworkers reported that cAMP stimulation reduced levels
of hydrogen peroxide, an important ROS, in human melanocytes after UV exposure
(Kadekaro, Chen et al. 2012).
Loss of function MC1R polymorphisms impedes accumulation of protective melanin in the
skin. MC1R deficiency is linked to skin cancer incidence. As we learn more about innate
signaling mechanisms that regulate natural antioxidant defense pathways in the skin such
as the MC1R hormonal axis, new approaches are being designed to exploit these
signaling pathways to delay or even prevent free-radical induced symptoms of aging. Use
of natural extracts such as forskolin enhance protection against UV-induce molecular
damage to the skin. cAMP-induced melanin deposition and antioxidant induction may
prove to be an important therapeutic opportunity to reduce UV-mediated pathologies.
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PROJECT OBJECTIVES
In this study, I explore the role of the MC1R pathway in protecting against UV-induced
sunburn and providing skin protection by enhancing expression of antioxidant enzymes in
the skin. We had previously demonstrated that the topical application of a cAMP activator
highly activates the MC1R pathway in Mc1re/e mice.
This study addresses the following issues in two chapters:
Chapter 2: MC1R signaling pathway promotes epidermal pigmentation and protect
against sunburn.
Chapter 3: MC1R signaling pathway increases MnSOD levels is the mitochondria and
does not affect mitochondrial oxidative phosphorylation.
In chapter two, I hypothesize that a short-term topical activation of MC1R/cAMP pathway
decreases UV sensitivity in Mc1re/e Tyr+/+ mice. Our laboratory previously reported the
development of a K14-SCF mouse model with a robust deposition of black melanin
pigment due to the presence of epidermal melanocytes. Mc1r-defective fair-skinned mice
resulted in an accumulation of eumelanin and a UV-protected phenotype against skin
sunburn. In addition to this phenotypic effect, I studied the role of the MC1R pathway to
protect the skin at the molecular level.
In chapter three, I hypothesize that MC1R signaling protects against oxidative stress by
the enhancement of antioxidant cellular defenses. These results provided an insight about
a possible mechanism of MC1R signaling pathway to control biosynthesis and regulation
of antioxidant enzymes by enhancing their gene expression. Moreover, I explore the
protein levels of the MnSOD in human melanocytes. The results suggest that increases
MnSOD may not involve transcriptional up-regulation but rather MnSOD transport and/or
stability. Furthermore, I studied if there was any protective effect in mitochondria
metabolism after activation of the MC1R/cAMP signaling pathway.
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CHAPTER 2
MC1R signaling pathway promotes epidermal pigmentation and protect against
sunburn.
This chapter is based on work published as Amaro-Ortiz, A., Vanover, J.C., Scott, T.L.,
D'Orazio, J.A. Pharmacologic Induction of Epidermal Melanin and Protection against
Sunburn in a Humanized Mouse Model. J. Vis. Exp. (79), e50670, doi: 10.3791/50670
(2013).

INTRODUCTION
The most deadly form of skin cancer is melanoma. In the United States, there is a dramatic
increase in the incidence of melanoma among light-skinned individuals. Epidemiologic
evidence showed a 20 % increase in the frequency of melanoma in fair-skinned individuals
compared to dark-skinned individuals. UV radiation is a major environmental factor that
contributes to the increased risk to develop skin cancer. Long exposure to solar radiation
and the constant use of tanning beds increase the intensity of UV exposure to the skin.
UV radiation induces direct and indirect molecular damage that can lead to genetic
mutations. These mutations lead to proliferative skin cells that spread to other parts of the
body and produce the generation of tumors. In addition, early life episodes of skin sunburn
have been linked to an increase in melanoma risk. Still, skin pigmentation has a mayor
role to determine the risk of developing melanoma.
The ratio of dark eumelanin to reddish pheomelanin varies among individuals. I focused
on fair-skinned individuals with low levels of eumelanin because more UV photons can
penetrate into the skin. There is a direct correlation between melanoma risk and the
signaling ability to “tan” following UV exposure. The activation of the melanocortin 1
receptor (MC1R) pathway increases the levels of protective eumelanin in the skin. The
MC1R is a G-protein couple receptor located in the plasma membrane of melanocytes
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and mediates activation of adenylate cyclase to increase production of cAMP. The
secondary messenger cAMP allows activation of main regulators of melanin biosynthesis
as previously discussed. UV mediates MC1R activation allowing melanocytes
differentiation and melanin production. Melanin is a complex polymer produced in
melanocytes is deposited in keratinocytes to protect the skin against exposure to higher
and hazardous UV doses. The endogenous ligand of MC1R is the α-melanocytes
stimulating hormone, α-MSH. The ligand is a tripeptide that can activate the MC1R and
induce the tanning response thus reducing UV-induced DNA damage in human
melanocytes. However, the down-regulation of the MC1R pathway increases the levels of
non-protective pheomelanin in the skin. I was interested in the mechanism by which MC1R
mediates melanocyte protection against UV-exposure. I used extension mice (Mc1re/e
Tyr+/+) that model the fair-skinned humans with decreased MC1R signaling. This
transgenic model constitutively expressed K14 stem cell factor (SCF) allowing epidermal
melanocytes to be retained at the basal layer of the epidermis. However, non-transgenic
mice maintain its melanocytes on the dermis in hair follicles.
Our laboratory developed an animal model to address the mechanism of the MC1R
pathway. For this study, the mice used were wild type mice (Mc1rE/E Tyr+/+) darker-skinned
mice; extension (Mc1re/e Tyr+/+) fair-skinned mice due to decreased MC1R signaling. Our
previous research confirmed a melanizing effect of chronic topical treatments of forskolin
correlating with increased UV-resistance in extension (Mc1re/e Tyr+/+) K14-SCF animals.
In this chapter, I demonstrate that short-term application of forskolin also rescues MC1R
signaling pathway. Moreover, I measured the deposition of melanin pigment and tested
protection against UV-induced sunburn by measuring the minimal erythematous dose,
MED.
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SPECIFIC AIM:
To study the rescue of MC1R signaling pathway using forskolin
a)

To determine the role of forskolin after a short-term topical application.

b)

To determine the deposition of melanin after MC1R stimulation.

c)

To examine how MC1R activation protects the skin against sunburn.

METHODS AND MATERIALS
Protocols for murine experiments followed the guidelines for ethical conduct in the care
and use of animals and were approved by the Institutional Animal Care and Use
Committee at the University of Kentucky (Protocol # 00768M2004).
MOUSE COLONY
4 to 12 week old C57BL/6 extension non-transgenic and K14-SCF transgenic extension
males and females mice were used. The characteristic phenotype was blonde fur, pink
skin, dark footpads and nose tip. The mice showed pheomelanotic fur, pheomelanotic
epidermal skin (due to presence of interfollicular epidermal melanocytes).
REAGENTS AND MATERIALS
The following reagents were purchased commercially: Coleus Forskohlii 20% extract
(Buckton Scott USA Inc., Princeton NJ); Depilatory cream Nair (Church & Dwight,
Princeton , NJ); Xylazine (Anased Injection, Shenandoah, IA); Ketamine (Putney, St.
Joseph, MO.); Isothesia Isoflurane (Butler Schein, Dublin, OH); Propyl glycol (Amresco,
Solon, OH) and Ethyl Ethanol (Fisher, Waltham, MA.). The following materials were
purchased commercially: Chromameter CR-400 and data processor (Konica Minolta,
Ramsey, NJ); Electric Shears (Oster, Atlanta, GA); NIST Radiometer/Photometer Model
IL1400A, International Light, Newburyport, MA), and Germicidal Hg Lamb UV-B
(Westinghouse, Pittsburgh, PA).
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PREPARATION OF FORSKOLIN EXTRACT FOR TOPICAL ADMINISTRATION WAS FROM A CRUDE
ROOT OF THE PLECTRANTHUS BARBATUS (COLEUS FORSKOHLII) PLANT

The preparation of forskolin was made by solubilizing P. barbatus root extract 20% (ATZ
Natural, NJ) The root extract is prepare at 40% weight/volume in a standard dermatologic
base of 70% ethanol, 30% propylene glycol. After stirring for an hour at room temperature,
the slurry was centrifuged (1,500 x g, room temperature, for 15 minutes). The solution was
filtered through a 0.22µm cellulose acetate membrane to remove any residual insoluble
material from the extract. The extract maintained biologic activity for months at room
temperature.
PREPARATION OF C57BL/6 K14-SCF MICE FOR TOPICAL TREATMENTS
The mice were briefly anesthetized using intraperitoneal injection of a standard mixture of
ketamine (Putney, St. Joseph, MO.) and xylazine (AnaSed, Shenandoah, IO.) (Typically
0.04ml per 10g body weight of a mixture of 10mg/ml ketamine and 1.0mg/ml xylazine).
The dorsal fur was removed using electric shears equipped with a 0.25mm surgical
preparatory head followed by chemical depilation by Nair (Church & Dwight, Princeton,
NJ.). After 24 hours, the mice were treated in the dorsal skin with 400uL of 40% crude
forskolin extract; vehicle control animals received 70% ethanol, 30% propylene glycol
alone twice daily for 5 days (10 applications). Then, 48 hours after the last topical
treatment, the mice were anesthetized with ketamine and xylazine so that UV sensitivity
by calculation of “Minimal Erythematous Dose” (MED) could be determined. A UVocclusive tape was placed on the back of the mice. The mice were placed in a UV source
consisting of two Westinghouse F15T8UV-B lamps with a peak output of 313nm and a
range of 280 to 370nm based on the UV transmission rate as measured by the UV
Photometer. The UV exposure time was calculated for each desired dose based on the
UV output of the source. The mice were monitored for 24 to 48 hours to look for discreet
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areas of erythema (redness) or edema (swelling) corresponding to the anatomic sites
exposed to the specific dose of UV irradiation. The skin findings were documented
photographically. The skin color was measured by reflective colorimetry while the mouse
was briefly anesthetized by inhaled isoflurane (Butlet Schein, Dublin, OH). A Minolta
colorimeter was calibrated by placing the portable head on the standardized white surface
provided with the colorimeter.
STATISTICAL ANALYSIS
The data was analyzed between cohorts of replicate samples (n = 3) by one-way ANOVA
using the Bonferroni post-test (Graph Pad PRISM software).

p values <0.05 were

considered statistically significant.
RESULTS
FORSKOLIN-INDUCED MELANIZATION OF FAIR-SKINNED MICE.
I tested the rescue of the MC1R signaling pathway in the C57BL/6 extension nontransgenic and K14-SCF transgenic extension pheomelanotic (Mc1re/e, Tyr+/+) mice (Fig.
2-1A). The ears of the mice show the retention of melanocytes in the epidermis. The mice
were treated twice daily for 5 days with either vehicle (70% ethanol, 30% propylene glycol)
or 40% crude Coleus Forskohlii root extract (Fig. 2-2 B). The amount of melanization of
the skin was dose dependent. The concentration of forskolin was 80uM per dose per
application. The effects of topical application on the dorsal skin were inspected visually
and using a reflective colorimeter (Fig. 2-2B). I reported an accumulation of robust
epidermal darkening after the last application of the root extract in the C57BL/6 K14-SCF
transgenic extension mice but not in the C57BL/6 extension non-transgenic mice. These
results indicate the importance of the location of epidermal melanocytes in order to allow
pharmacologic stimulation of melanin to be deposited in the keratinocytes located in the
epidermis. Although the root extract contains plant photo-chemicals that contribute to its
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color, there is no skin darkening in non-transgenic animals. Therefore, the dyeing effect
from the drug has no contribution to the skin darkening (Fig. 2-2A). The topical treatment
of forskolin showed an effect as early as two days and continued to a maximal darkening
after several applications (Fig 2-2B).
TOPICAL FORSKOLIN DECREASES UV SENSITIVITY.
Next, I determined the effect of the topical application of forskolin on UV sensitivity by
testing MED in C57BL/6 K14-SCF transgenic extension mice. I compared this group with
non-transgenic mice as a control for the non-forskolin component of the root extract. The
reflective colorimetric white-black scale L* value was 31.9 ± 1.8 kJ/m2 compared to 3.8 ±
1.8 kJ/m2. Actually, a dose of 30 0 kJ/m2 did not generate erythema in the dorsal skin. This
was expected since the mice show no obvious side effects after the scheduled 10
applications; thus, I concluded that twice-daily administration of forskolin induces a nontoxic and safe melanization.

The MED was measured 2 days after the last topical

application of forskolin, thus non-pigmentary effect of cAMP have no role in MED results
(Fig 2-3A,B). Thus, whereas mean MED for K14-SCF extension mice treated for twice for
5 days with vehicle was 5.0 ± 0.0 kJ/m2, average MED for cohorts treated with topical
forskolin was > 30.0 ± 0.0 kJ/m2. In fact, a dose of 30.0 kJ/m2 was insufficient to generate
erythema in this experiment. There was no significant difference when I compared nontransgenic and K14-SCF transgenic extension treated with vehicle (70% ethanol, 30%
propylene glycol). I reported an L* value of 3.3 ± 1.4 kJ/m2 compared to 5.0 ± 0.0 kJ/m2,
respectively. Overall, forskolin induces epidermal melanization and provides a decrease
in UV sensitivity in fair-skinned individuals.
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Figure 2-1. Topical treatment of forskolin promotes skin darkening in fairskinned extension.
(Mc1re/e) mice photographs of C57BL/6 animals used in this study. Animals are
genetically matched except at the melanocortin 1 receptor (Mc1r). Note that
pigmentation is eumelanotic (black) when Mc1r is functional but pheomelanotic
(blondish) when Mc1r is defective, as is the case with the extension (Mc1re/e)
mutant. Epidermal pigmentation depends on retention of interfollicular epidermal
melanocytes in the skin by the K14-SCF transgene, and the skin darkening can
easily be seen in the ears.
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Figure 2-2. Twice daily application of Forskolin induces MC1R signaling.
(A) Photographs of extension (Mc1re/e) K14-SCF or non- transgenic animals
treated with 400uL of vehicle control (70% ethanol 30% propyl glycol) or 40% w/v
(80 µM) forskolin applied twice daily to the shaved dorsal skin for 5 days, total of
10 applications. Skin color measurements by reflective colorimetry were
performed for each group. Reflective colorimetry results are reported as mean (±
SD) reflectometry units on the L* (white-black) color axis. Note that topical
administration of forskolin caused robust skin darkening in K14-SCF transgenic
animals but not in non-transgenic mice. (B) Time course experiment showing
darkening of the forskolin-treated ear of K14-SCF extension mice for the indicated
times (forskolin-treated ears are indicated by the blue triangles). Vehicle was
applied to the right ear for comparison. The L* ± SD results are reported as
reflective colorimeter white-black scale, * p ≤ 0.001.
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Figure 2-3. Forskolin-induced melanization protects against UV-mediated
inflammation as determined by minimal erythematous dose (MED) testing.
(A, B) Position of UV occlusive tape and UVB doses of animals treated twice daily
for 5 days. The last topical treatment was applied 48h prior to irradiation. Dorsal
skin was exposed to various doses of UVB by using UV-occlusive tape with
punched-out 1 cm2 circular apertures, and varying exposure times to yield the
appropriate dose. After irradiation, circles of exposed skin were labeled with a pen
in some experiments. MED’s, defined by erythema and/or edema of the entire
circle of exposed skin to a particular dose, were determined 48 hours after
exposure. The MED ± SD results are reported as kJ/m2 UVB, * p ≤ 0.001.
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DISCUSSION
It is vital to select a functional mouse model to study skin melanization. There are
differences between human and mice skin such as thickness, epidermal melanocytes, and
dermis structure. UV mediates expression of MC1R endogenous ligand α-MSH in
keratinocytes. Nevertheless, in Mc1re/e mice, there is no UV-mediated melanization due
to MC1R deficiency, and these mice have higher levels of pheomelanin or red/blonde
pigment than the dark pigment eumelanin. Similarly, there is no UV- or forskolin- induced
pigmentation in K14-SCF non-transgenic mice. In that case, pharmacologic stimulation
such as forskolin-mediated cAMP signaling of the adaptive pigmentation pathway provides
UV protection for fair-skin mice.
UV sensitivity is a common characteristic in humans unable to tan after long
exposure of solar radiation. The deficiency in the production of melanin allows higher dose
of UVB to penetrate the skin and induce UV-damage. I hypothesized that the use of
forskolin as a short-term treatment allows the accumulation of melanin in Mc1r-deficient
mice. I used a mouse model of the fair-skinned individuals and I found that topically applied
crude extract of forskolin induced skin darkening by increasing the synthesis of melanin
production in the skin. This model mimics the complexion of human skin, retaining
epidermal melanocytes compared to non-transgenic mice with dermal melanocytes
unable to produce melanin. This was possible by the expression of the stem cell factor
K14 at the epidermal basal layer in transgene mice to mimic what occurs in human skin.
The location of interfollicular melanocytes is key to obtain an accumulation in melanin. Our
laboratory animal model include the K14-SCF transgene on C57BL/6 extension (Mc1re/e
Tyr+/+). Mutated MC1R down-regulates the production of cAMP signaling leading to a
pheomelanotic phenotype. However, K14-SCF Mc1re/e Tyr+/+ mice showed an abundant
accumulation of protective eumelanin when treated with forskolin. Therefore, the use of a
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pharmacologic stimulation of MC1R is able to rescue and balance the production of
eumelanin in a fair-skinned background. The mechanism of activation of the MC1R has
been well established. MC1R is able to induce cAMP production leading to pro-survival
and pro-differentiation signals to melanocytes. However, direct activation of the adenylate
cyclase is able to bypass mutations of MC1R signaling. I selected the crude root extract
of forskolin as a natural option for a topical treatment against hazardous UV exposure
because use of the purified forskolin was not cost-effective for topical treatments. Previous
studies from our laboratory showed the use of 40% weight per volume solution of the root
extract containing 80uM of forskolin. Here I showed that this dose induces darkening in
the skin after the first two applications. I reported that twice-daily application is associated
with a clear darkening of the skin providing significant UV protection. Compared to
previous studies, our data reports that forskolin can be administrated more than once a
day and be tolerated by the mice. There is no swelling of the skin after forskolin is applied.
Therefore, the darkening of the skin is due to accumulation of eumelanin and not
proliferation of the cells in the epidermis. When topical treatment were discontinued, the
dorsal skin gradually returns to its pheomelanotic complexion.
Based on the data, pharmacologic activation of cAMP showed a significant
increase in UV-protection as suggested by measuring the minimal erythematous dose
(MED). The MED is the lowest dose of UV that induces erythema of the skin. The K14SCF transgenic extension mice that were treated with forskolin showed > 6 fold increase
in MED compared to non-transgenic extension mice. The use of topical stimulation of
cAMP rescues melanin synthesis and induces MC1R-dependent signaling providing
protection against UV-induced skin injury.
This study has many implications for the prevention of UV-induced skin damage.
The skin is constantly exposed to environmental factors, of which solar radiation is a major
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carcinogen. Topical pharmacologic activation of MC1R/cAMP provides a possible
therapeutic target against individuals unable to tan and who are prone to skin mutagenesis
(D'Orazio, Nobuhisa et al. 2006). Forskolin induces darkening of the skin by activating the
synthesis of endogenous melanin. The skin will fade back to its baseline skin complexion
once the treatment is removed. Therefore, a persistent application is required to maintain
darkening of the skin. Forskolin can effectively induce skin darkening and increase UV
sensitivity by increasing MED in mice, establishing a proof-of-concept to test the ability of
forskolin to rescue deficiencies in the MC1R/cAMP signaling pathway. The study of role
of forskolin at the molecular level will provide a mechanism of action to determine how to
use this potent drug as a topical treatment.

Copyright © Alexandra Amaro-Ortiz 2015
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CHAPTER 3
MC1R signaling pathway increases MnSOD levels in the mitochondria and does not
affect mitochondrial oxidative phosphorylation.
INTRODUCTION
This chapter is focused on the regulation of antioxidant defenses in melanocytes. In the
skin, melanocytes are located in epidermis and the accumulation of UV-induce damage
could lead to melanocyte transformation into melanoma. Antioxidant enzymes are the first
line of defense against an increase in ROS. Interestingly, the cell produces endogenous
levels of ROS that are able to regulate and to impair cellular signaling pathways. Moreover,
mitochondrial production of endogenous levels of ROS in the cell is tightly regulated by
antioxidant enzymes.
SODs are the only antioxidant enzymes that are able to interact with a radical and
converted it to two different species, H2O2 and O2. MnSOD is located in the mitochondria
and knockdown of this enzyme leads to cell death. It is an essential protein regulated by
NF-κB. It is not clear what happens once MnSOD engages to superoxide radicals but it is
known that it can be inhibited by OONO- (Kim, Rodriguez et al. 2001). There are limited
studies considering the role of MnSOD in the skin (Yan, Li et al. 1999, St Clair, Zhao et al.
2005, Luanpitpong, Chanvorachote et al. 2012, Holley, Xu et al. 2014), especially in
melanocytes, the precursor of melanoma.
Preliminary data from our laboratory showed a correlation between the level of MITF and
the presence of mtDNA damage in the cell. Different human melanoma cell lines were
tested for the expression of MITF (Figure 3-1A). WM1366 and 451Lu were the cell lines
with the highest protein levels for MITF and the lowest amount of mtDNA lesions. These
lesions were measured by mtDNA amplification after UV exposure (Figure 3-1B). The
small and circular mtDNA is more prone to mutation than nuclear DNA (Larsson and
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Clayton 1995),(Nagley and Wei 1998). A faster amplification of different mtDNA fragments
represents a higher frequency of DNA lesions. We found that the use of an oxidative agent
such as H2O2 caused increases in mtDNA mutation in cell lines that expressed low levels
of MITF (Fig. 3-1B). In addition, there was a decrease in the amount of mutation frequency
present in human cell lines after UV exposure with rescue of MC1R/cAMP signaling (Fig.
3-1C, D). The cell lines were treated with chloramphenicol (CAP), an antibiotic whose
mechanism of action allows study of mtDNA mutagenesis. CAP binds to mitochondrial
ribosomes inhibiting mitochondrial protein synthesis and cellular proliferation. Treating cell
lines with sub-lethal doses of UVB allows cells to incorporate mutations that will impair
ribosome structure and interfere with CAP binding because of UV-induced DNA mutations
to rDNA sequence. If mutations are generated after UV exposure, CAP cannot bind to
ribosomes, and cells can grow as a result in its presence. After incubating cells with
forskolin as a cAMP activator, the cells were irradiated. The cells that generated mutation
on its DNA after UVB exposure were able to proliferate. Forskolin pretreatment decreased
mutation frequency from 7 x10-4 to 3 x10-4 in A375 cell line (MC1R R151C) and from 6
x10-4 to 2 x10-4 in SBCL2 (wild-type MC1R) cells, suggesting that cAMP signaling protects
against UV-mediated mitochondrial mutagenesis (Fig. 3-1C, D). We conclude that MC1R
signaling has a protective effect against UV-induced mitochondrial mutagenesis.
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Figure 3-1. The level of mtDNA damage in melanoma cell lines.
(A) MITF expression in melanoma cells at various stages of progression. Cells were
serum starved for 24h and whole cell lysate was probed for MITF levels. (B) H2O2induced mtDNA damage in a panel of melanoma cells. Cells were serum starved for
24h and then exposed to oxidative stress (100 μM H2O2) for 30 minutes immediately
following damage, DNA was isolated and XL-PCR performed. A 10kb primer set
specific to the mitochondrial genome was used to determine levels of mtDNA
damage. (C) Chloramphenicol (CAP) resistance assay for wild-type and mutated
MC1R. Cells were treated twice to a sub-lethal dose of UV before incubation with
CAP growth media for two weeks until cell colonies developed. (D) Representative
pictures of colonies. VGP (Vertical growth phase), RGP (Radial growth phase) & MET
(Metastatic phase)
Experiment performed in collaboration with Dr. Stuart Jarrett, PhD.
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In this chapter, I studied the role of the rescue of MC1R pathway to enhance the
expression of several genes that have a role in the oxidative stress regulation. Several
studies confirmed that MITF plays a role in skin other than by inducing melanin production
(Kim, Kim et al. 2005, Carreira, Goodall et al. 2006, Liu, Fu et al. 2009, Yi, Zhao et al.
2011, Berwick, MacArthur et al. 2014). Nonetheless, there is limited evidence of specific
induction of the gene expression of antioxidant enzymes after activation of MITF in
melanocytes.
In addition, I studied activation of MC1R signaling and its role in the translocation of the
antioxidant enzyme MnSOD.

I hypothesized that MC1R/cAMP increases the gene

expression of MnSOD. I tested the role of MC1R in the induction of MnSOD protein levels
and activity. Lastly, I explored the role of the MC1R in mitochondria metabolism as a
potential functional effect of MC1R pathway. The MC1R/cAMP might be a potential target
for the induction of antioxidant defenses after exposure to solar UV.
SPECIFIC AIM:
To study the role of MC1R in antioxidant defenses and mitochondrial oxidative
phosphorylation.
a)

To explore the expression of oxidative stress related genes after pharmacologic

induction of the MC1R pathway.
b)

To study a mechanism of levels/activity of MnSOD after activation of the

MC1R/cAMP signaling pathway.
c)

To examine the role of MC1R/cAMP in mitochondria metabolism.

METHODS AND MATERIALS
CELL LINES AND PLASMIDS
A375, SKMel2 and HEK293 cell lines were purchased from ATCC. pcDNA3.1/MnSOD
(human) 3`-FLAG-MnSOD was provided by Dr. Jian-Jian Li from the University of
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California Davis. WT MC1R and mutated MC1R R160W were constructed with the Quick
Change Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA.). Mouse primary
melanocytes were isolated from C57BL/6 extension K14-SCF transgenic extension.
REAGENTS
The following antibodies were purchased commercially: SOD2
(Pierce-Thermo Scientific, Waltham, MA.);

GSR

(1H6; western blot)

and GPX antibodies (Santa Cruz

Biotechnology, Santa Cruz, CA.); GAPDH (Life Technologies, Grand Island, NY); VDAC,
HSP70, FLAG (DKDDDDK),PKA P/S antibodies (Cell Signaling, Boston, MA.); HRPconjugated secondary antibodies (Abcam, Cambridge, MA.)

SOD determination kit

(Sigma-Aldrich, St. Louis, MO.) and the Seahorse Analysis reagents (Seahorse
Bioscience Massachusetts, USA.)
ISOLATION OF PRIMARY MELANOCYTES
The protocol used was published from our laboratory from the article of Scott and
colleagues (Scott, Wakamatsu et al. 2009). The primary murine cells were obtained from
Mc1re/e Tyr+/+ C57BL/6J animals unless otherwise stated. Melanocytes were selected for
and grown in a Ham’s F12 media and established normal murine keratinocyte conditioned
media mixture.
MRNA ISOLATION FROM TISSUE SAMPLES

Skin biopsies were taken at indicated time-points. Skin tissues were ground in liquid
nitrogen with a mortal and pestle. The skin was homogenized with Trizol® reagent
following manufacturer protocol. The mRNA was processed using the RNAeasy kit
(Qiagen, Valencia, CA.) following manufacturer’s instruction. mRNA was quantified,
normalized and converted to cDNA using the iScript cDNA kit (Qiagen, Valencia, CA.).
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qPCR
The cells were plated in 35mm dishes and with 10µM forskolin or 0.1% ETOH. Untreated
cells served as control samples. The cells were dissociated by treatment with 0.25%
trypsin/EDTA at 37°C for 5 min. The cells were harvested, centrifuged and RNA was
isolated using the RNAeasy kit (Qiagen, Valencia, CA.). RNA was converted to cDNA
using the iScript cDNA kit (Qiagen, Valencia, CA.). The cDNA from mouse tissue was
used to perform quantitative PCR assay by the LifeCycle Real-time PCR (Roche,
Indianapolis, IN) with the β-actin as a reference gene included for each reaction. The
levels of expression of genes in stimulated cells were compared with the untreated control
groups. The cDNA from human melanocytes was used to perform quantitative PCR assay
by the CF-96 Biorad qPCR with the 18S as a reference gene included for each reaction.
The levels of expression of genes in stimulated cells were compared with the untreated
control groups.
XL-PCR
Genomic DNA was extracted using a commercially available Qiagen genomic-tip kit
(Qiagen, Inc., CA). The quantitative polymerase chain reaction (qPCR) assay measures
the average oxidative lesion frequency on mtDNA. DNA damage was quantified by
comparing the relative efficiency of the amplification of a 13.4kb mtDNA gene fragment
and normalized to 250bp fragment (this small fragment has a statistically negligible chance
of sustaining oxidative stress-induced base damage). PCR conditions used in this study
were based on previously reported sequences for mtDNA primers (Ayala-Torres, Chen et
al. 2000, Jarrett and Boulton 2005). qPCR was carried out on a DNA Engine thermal
cycler with all reactions being a total volume of 100μl containing 15ng of total genomic
DNA, 1unit of XL rTth polymerase, 3.3 XL PCR buffer II (containing potassium acetate,
glycerol and DMSO) and final concentrations of 200μM dNTP`s, 1.2mM Mg(OAc)2 and
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0.1μM primers. The gene fragments were amplified using the following thermo-cycling
profile: The PCR was initiated with the addition of the 1 unit of XL rTth polymerase when
samples had reached a temperature of 75°C. This was followed by an initial penetration
for 1 min at 94°C, cycles of denaturation at 94°C for 30s and primer extension at 60°C for
13 min. After the PCR cycles had been completed, a final extension at 72°C for 10 min
was performed. The nuclear and mitochondrial gene products underwent 28 cycles and
26 cycles of thermo-cycling, respectively. After the completion of the qPCR, the gene
products were resolved on a 1% agarose gel and digitally photographed on a UV
transilluminator (UVi Tec, UK). The intensity of the PCR product bands was quantified with
Scion Image analysis software (Scion Corporation, Version Beta 4.0.2).
CHLORAMPHENICOL RESISTANCE ASSAY
Chloramphenicol (CAP)-resistance was measured as a measurement of mtDNA
mutagenesis. A375 cells were seeded onto 6-well dishes at 500 cells/well. After the
24 hours of incubation, the growth medium was replaced with medium containing 10uM
Forskolin and incubate for 24 hrs. The cells were irradiated at a sub-lethal dose of UVB
(5J) and incubate for 24 hours. If the experiment responded to a schedule of treatments,
step 2 is repeated before each irradiation. At the end of all treatments, the cells were
incubated with growth medium containing 1mM CAP. The cultures were maintained until
colonies visible to the naked eye were formed; the colonies were then fixed with methanol
and stained with 0.5% crystal violet in 50% methanol (roughly takes 2 weeks). The
mutation frequency is calculated by dividing the existing colonies by the amount of cells
plated.
WESTERN BLOT, IMMUNO-PRECIPITATION AND ACTIVITY ASSAY
Cell lines were lysed in RIPA buffer (25mM Tris-HCl pH 7.6, 150mM NaCl, 1% NP-40, 1%
sodium deoxycholate, 0.1% SDS and 1X Halt Protease and Phosphatase Inhibitor
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Cocktail, EDTA-Free (Thermo Scientific, Waltham, MA.)). Total protein was quantified
using Pierce BCA protein assay (Thermo Scientific, Waltham, MA.). The amount of protein
per sample was normalized and loaded onto SDS-PAGE gels. Immunoblotting was
performed using antibody manufacturer protocols. Immuno-precipitations were performed
with equal amount of total protein incubated overnight at 4°C with 5μg of antibody and
protein G agarose, washed three times with RIPA buffer, and separated by SDS-PAGE
prior to immunoblotting. For indicated experiments the SDS-PAGE gel was stained with
Colloidal blue. Several bands were selected for their identification at the Proteomic facility
of the University of Kentucky. All immunoblotting was performed with enhanced
chemiluminescence (ECL) and quantified with the STORM system. Bands were quantified
using Image J (NIH, Bethesda, MA.). Equal mitochondrial and whole cell protein were
used for the SOD determination assays, and the assay was performed as previously
described (MacMillan-Crow, Crow et al. 1996) and following manufacture’s protocol
(Cayman Chemical Co. Ann Harbor, MI.). Potassium cyanide (KCN) 1mM solution was
used as an inhibitor of Cu/ZnSOD and ECSOD at indicated experiments.
MITOCHONDRIA ISOLATION
The cells were plated in 150mm dishes and treated for cAMP stimulation. Treatments
included 10µM forskolin or 0.1% vehicle control and untreated cells as the control
samples. The cells were dissociated by treatment with 0.25% trypsin/EDTA at 37°C for 5
min. The cells were harvested, centrifuged and mitochondria were isolated using a buffer
containing 10mM NaCl, 1.5mM MgCl2, 10mN Tris-HCl, pH 7.5. Cells were homogenized
on ice and centrifuged. The sucrose gradient was prepared with a 2M sucrose solution in
10mM Tris-HCl and 1mM EDTA (TE buffer) following indicated dilutions. Pelleted material
was layered on a 1:1 mixture of 1.7M sucrose and 1.0M sucrose and centrifuged at 24,000
rpm for 40 min. The fraction containing mitochondria was washed in TE buffer and
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centrifuged for 10 min at 13,000 rpm. The pellet (mitochondria) was re-suspended in
250nM sucrose. The solution was diluted in RIPA buffer.
TRANSFECTION FLAG-TAGGED MNSOD PLASMID
Designated cell lines were plated in 35mm dishes and transfected with 3`-FLAG-MnSOD,
pcDNA3.1, MC1RE/E and MC1RR160W using Effectene Transfection Reagent (Qiagen,
Valencia, CA.) according to manufacturer protocol.
PROTEIN KINASE ASSAY
PKA kinase assays were initiated by incubating 10nM recombinant catalytic subunit of
PKA enzyme (Invitrogen, Grand Island, NY.) and HA-tagged MnSOD (Fitzgerald, Acton,
MA.) at 30°C for 10 min, in 40mM Tris-Cl (pH 7.5), 10mM MgCl2, 1mM DTT, 100μg/ml
BSA, and 10μM ATP. The reaction was stopped by the addition of 10μl of 100mM EDTA.
The extent of PKA phosphorylation was measured by immune-blot with antiphosphoserine (Abcam Cambridge, MA.). HA-tagged MnSOD was immunoprecipitated
with anti-HA overnight at 4°C and protein G agarose, washed five times with RIPA buffer,
and separated by SDS-PAGE prior to immunoblotting. All immunoblotting was performed
with enhanced chemiluminescence (ECL) and quantified with the STORM system.
SEAHORSE ANALYSIS
Seahorse analysis experiments were performed after cAMP stimulation for 1, 3, 6 and 24
hours with 10uM forskolin or 0.1% ETOH before exposure to UVB consisting of two
Westinghouse F15T8UV-B lamps at 500, 1000, 1500 and 5000 J/cm2. Oxygenconsumption rates (OCR) was analyzed at the University of Kentucky Free Radical
Biology and Cancer Shared Facility. OCR was controlled at all times during the experiment
to exclude any pathway independent effect. Fccp, an uncoupling agent, was used to
accelerate the electron transport chain (ETC), and doses were optimized together with
amount of cells per experiment. Then, the Seahorse system measured the OCR (ρmol)
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and what impact cAMP stimulation has on oxidative phosphorylation. The OCR was
measured in triplicate during maximal respiration controlled by fccp and in the presence
of rotenone as an ETC inhibitor. Values were normalized to the protein concentration per
sample, and OCR levels were compared between untreated vs cAMP-stimulated
conditions.
STATISTICAL ANALYSIS
The data was analyzed between cohorts of replicate samples (n = 3) by one way ANOVA
using the Bonferroni post-test (Graph Pad PRISM software).

p values <0.05 were

considered statistically significant.
RESULTS
MC1R INCREASES EXPRESSION OF ANTIOXIDANT ENZYMES AT THE TRANSCRIPTION LEVEL.
I explored the role of the MC1R as a regulator of the gene expression of several
antioxidant enzymes. Although MC1R pathway has been well described as a potent
regulator of melanin production and skin pigmentation, there are limited studies looking at
its role in the expression of antioxidant enzymes in the skin. Mc1re/e Tyr+/+ extension mice
were used (the same mice that showed rescue of melanin synthesis after forskolin
treatment). I performed a kinetic experiment measuring mRNA expression of MnSOD,
CAT, GPX and Nfe2l1 or NRF2 (Figure 3-2). There was a 2.5-fold increase for the
expression of SOD2 after 6 hours of topical forskolin treatment. Gene expression of MITF
was used as an internal control for the experiment. There was no significant difference for
other antioxidant enzymes compared to the 0 hour time-point. An important caveat to
consider was that mRNA was isolated from whole skin samples (dermis and epidermis)
from which melanocytes constitute roughly 10 percent of the cells present. Since MC1R
is located in the plasma membrane of melanocytes, I isolated primary melanocytes from
Mc1re/e Tyr+/+ mice. I tested the expression of MITF in these primary cells and there was
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an increase in MITF gene expression 3, 6 and 24 hours after forskolin treatment (Figure
3-3A). α-MSH was included in this experiment as a negative control in these MC1Rdefective cells, and there was no induction of MITF after α-MSH treatment. Gene
expression of SOD2 nor NFE2l2 (NRF2) increased after FSK treatment, suggesting that
perhaps SOD2 and NRF2 are not target of the transcription factor MITF in mouse
melanocytes. Then, human melanoma cell lines with mutated MC1R R151C were tested
for the expression of MITF after forskolin treatment in several time points (Figure 3-3B).
There was an increase of MITF expression in a time dependent matter with the higher
expression at 6 hours. I selected the 6 hour time point to analyze a gene array that
included antioxidant enzymes, several transcription factors and other protein regulators
by qPCR. An oxidative stress panel for 60 genes was tested in response to MC1R
activation. Out of the genes tested, 22 showed a positive response (at least two-fold
increase). Of these, FOXO1, BCL2, JUN, MAPK1, 3 &9, STAT1, HSPD1 & DDIT3 were
induced. These genes are known to have a role in the regulation of apoptosis. The TLR4
is a Toll-like receptor was increased together with the inflammatory cytokine IL1B. The
activation of the adaptive immune system is considered a protective effect in the skin since
it promotes healing in the skin after UV-induced sunburn (Greene, Hoover et al. 1978).
Moreover, there was an increase in the expression of the antioxidant enzymes SOD1,
GPX1, & 3, Nrf2 and NF-κB. Both Nrf2 and NF-κB were upregulated to a 6 and 4-fold
increase, respectively. RELA is a subunit of NF-κB and its expression was increase as
well. Interestingly, some downstream targets of Nrf2 and NF-κB did not show a significant
effect after MC1R activation by forskolin in human melanocytes. For example SOD1, 2 &
3 were down-regulated and they are known to be activated by NF-κB. Nrf2 regulates the
expression of GSTP1 and GCLC. Both are involved in the glutathione pathway and their
gene expression after the 6-hour time point was down regulated. Additional kinetics
experiments are require to address the effect on MC1R on these genes. There was no
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increase in the expression of several antioxidant enzymes (CAT, TP53, MDM2 among
other genes relative to the expression of GAPDH) (Table 3-1), but there were significant
increases in the expression of PRDX3 and MAPK9 (Table 3-1). Although some genes
were down regulated, MC1R activation had a role in the up-regulation of several regulators
of antioxidant enzymes and oxidative stress related genes at the transcriptional level.
MC1R INCREASES MNSOD PROTEIN LEVELS IN MITOCHONDRIA AT EARLY TIME POINTS.
I wanted to study the role of MC1R in the protein levels of MnSOD in melanocytes. There
was no significant increase in the protein levels of MnSOD (Figure 3-4A), from 1 to 24
hours after cAMP stimulation in whole cell lysate. The protein levels of GSR and GPX
(Figure 3-4B) did not increase after a treatment of 6 hours. However, there was an
increase in the protein levels of MnSOD in mitochondria lysate at early time points (Figure
3-4C, D). Furthermore, there was an increase in MnSOD protein levels after cAMP
stimulation plus 50J UVB or 50uM of H2O2 in mitochondria isolated from MC1R R151C
melanocytes (Figure 3-5) after 1 hour of forskolin treatment. I transfected human
embryonic kidney cells (HEK293) with wild-type and mutated MC1R to test for the protein
levels of MnSOD. There was a significant increase in the levels of MnSOD in MC1R
R160W with forskolin (Figure 3-6). However, HEK 293 transfected with wild-type MC1R
showed no induction of the protein levels of MnSOD. These results at early time points
suggesting that the up-regulation of MnSOD protein levels may not involve transcriptional
up-regulation but rather MnSOD transport and/or stability.
MC1R SIGNALING INCREASES MNSOD INTERACTION WITH CHAPERONE PROTEIN HSP70.
To investigate the possibility that cAMP-mediated increases in MnSOD were regulated by
binding partners, I made used of FLAG tagged-MnSOD constructs obtained from Dr. JianJian Li from the Comprehensive Cancer Center at UC Davis. I tested MC1R R151C cells
after 10uM forskolin and 50uM H2O2 treatment for 1 hour. Cellular lysates were
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immunoprecipitated for FLAG and analyzed by western blot. The SDS-PAGE gel was
stained with colloidal blue and treatments were compared. The bands that increased or
decreased by forskolin treatment were selected and removed for the gel to be sent for
analysis. A band close to the 70 kDa size was sent for identification with the proteomic
facility (Figure 3-7A). They identified it to be heat shock protein 70 (HSP70) increased in
associated with FLAG-tagged MnSOD after forskolin treatment. I tested the cell line with
forskolin followed by 30 minutes of hydrogen peroxide and found an increase in the
interaction of HSP70 with FLAG after treatment with forskolin (Figure 3-7B, C). HSP70
was also increase in the western blot for whole protein without IP. However, when the
cells were treated with H2O2 the whole cell increase of HSP70 did not change. But, the
interaction remained in the IP FLAG-tagged MnSOD after H2O2 treatment. HSP70 is a
chaperone protein that is found in the cytoplasm. As a chaperone, it has a role of
transporting proteins around the cell and HSP70 is linked to translocation of glutathione
to the mitochondria (Guo, Wharton et al. 2007).
MNSOD INTERACTION WITH HSP70 IS PKA DEPENDENT.
I wanted to test if PKA had a role in the increase of HSP70 interacting with FLAG taggedMnSOD. I tested the inhibitor H89 that blocks the PKA catalytic subunit (Figure 3-8A). I
treated FLAG tagged-MnSOD A375 (MC1R R151C) cell line for one hour with H89. Then,
the cells were treated with 0.1% ETOH and 10uM forskolin for 1 hour. I saw a decrease in
the interaction between HSP70 and FLAG. I tested doses of H2O2 and chose 50uM for 30
minutes (Figure 3-8B). I observed no increase in HSP70 after I.P. with FLAG after adding
H89. The protein sequence of MnSOD identified two possible PKA phosphorylation sites
potentially explaining cAMP-enhanced interactions with HSP70. These sites could be
used as target in future studies for site-directed mutagenesis to continue further studies
about HSP70 interaction with MnSOD
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FORSKOLIN RESCUE OF MC1R SIGNALING INCREASES MNSOD ACTIVITY.
I wanted to investigate whether the protein levels of MnSOD and its interaction with HSP70
might result in an increase in MnSOD protein activity. I tested weather cAMP affects the
activity of MnSOD using the Superoxide Dismutase Assay Kit (Cayman Chemical Co.,
Ann Harbor, MI). Total protein (whole cell) was isolated from MC1R R151C cell lines.
Efficacy of superoxide removal using xanthine oxidase as a standard for ROS production
(Figure 3-9) was quantified. There was an increase in the levels of superoxide dismutase
activity after 1 and 3 hours of forskolin treatment in whole cell lysate (Figure 3-9A). These
results include the activity of Cu/ZnSOD, MnSOD and ECSOD. Potassium cyanide (KCN)
was added to the protein solution to inhibit the activity of Cu/ZnSOD and ECSOD. The
inhibition of Cu/ZnSOD and ECSOD enable the detection of MnSOD activity exclusively.
Figure 3-9A shows no significant difference in MnSOD activity between each time point in
whole cell protein lysate. The concentration of xanthine oxidase was decreased within
minutes of the reaction and there was no difference between forskolin and vehicle.
However, whole cell lysate treated with KCN showed a significant decrease in the
presence of forskolin. Interestingly, there was an increase in MnSOD activity (U/mg) at the
one hour time point (Figure 3-9B). Then, mitochondria protein lysate was tested together
with potassium cyanide to measure MnSOD activity. Similarly, there was an increase at
the one hour time point after forskolin treatment. Therefore, I concluded that the activation
of MC1R/cAMP signaling increased MnSOD activity at early time points.
MC1R SIGNALING DOES NOT AFFECT MITOCHONDRIA METABOLISM.
MnSOD is an antioxidant enzyme located in the mitochondria. I wanted to investigate if
there was any effect in mitochondria metabolism after forskolin treatment. Seahorse
analysis was optimized to test the oxygen consumption rate (OCR) after stimulation of
cAMP in MC1R R151C cells (Figure 3-10). I tested the effects of one hour treatment in
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order to compare the results with the protein levels and immune-precipitation assay. The
results are shown as OCR percentage (A) and OCR concentration at ρMol/min. There was
no increase in the OCR after cAMP stimulation at the basal metabolism, ATP production
or maximal respiration. I included a dose of UVB irradiation of 50J to test effect UV as a
positive control and investigated a possible protective effect after forskolin treatment.
There was no significant difference between forskolin plus UVB and UVB alone within the
same phase of mitochondria metabolism. However, there was a significant difference in
the levels of maximal respiration comparing forskolin plus UVB with UVB alone.
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A

Figure 3-2. MITF and SOD2 gene expression were rescued after forskolin
treatment in whole skin tissue.
Mc1r e/e Tyr +/+ were treated with 40%w/v Forskolin and vehicle control (70% ETOH,
30% PG) for 1 to 6 hours. Skin biopsies were taken and mRNA was isolated and
analyzed by qPCR using primers specific for mouse mRNA. The gene amplification
was normalized to 18S and the relative amplification levels at all-time points after
forskolin and vehicle treatment were normalized to 0 hours control.
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A

B

Figure 3-3. MITF gene expression was rescued after forskolin treatment.
(A) Mc1r e/e Tyr +/+ primary melanocytes were treated with 10uM Forskolin and 0.1%
ETOH for 3 to 24 hours. mRNA was isolated using RNAeasy kit (qiagen). The
samples were analyzed by qPCR using primer specific for mouse mRNA. (B) Human
melanocytes MC1R R151C were treated with 10uM Forskolin and 0.1% ETOH for
0.5 to 6 hours. mRNA was isolated and analyzed with qPCR using primer specific for
human mRNA. The gene amplification was normalized to 18S (A) or GAPDH (B) and
the relative amplification levels at all time-points after forskolin and vehicle treatment
were normalized to 0 hours control.
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Table 3-1. Antioxidant enzymes gene array expression after forskolin
treatment.
Human melanocytes (MC1R R151C) were treated with 10uM Forskolin and 0.1%
ETOH for 6 hours. mRNA was isolated and analyzed with Primer PCR Assay for
oxidative stress pathway (Biorad, Hercules CA.) using primer specific for human
mRNA. The gene amplification was normalized to GAPDH and the relative
amplification levels after forskolin treatment were normalized to vehicle control (0.1%
ETOH).
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Figure 3-4. MnSOD protein expression did not change after forskolin treatment
in whole cell lysates but did increase in mitochondria.
Human melanocytes MC1R R151C were treated with 10uM Forskolin and 0.1% ETOH
for 30 minutes to 24 hours. Whole cell (A, B) and mitochondria (C, D) protein was
isolated and quantified to be examined by western blot. (B) The cells were treated for
6 hours with or without 50uM H2O2. (C) The cells were treated for 30 min. with 10uM
forskolin and 50J of UVB. (D) The cells were treated for different time-points with 10uM
forskolin and 0.1% ETOH. The relative expression of MnSOD (relative to loading
control GAPDH (cytoplasm) or VDAC (mitochondria)) was graphed after forskolin
treatments were normalized to initial time-point.
Panel C was performed by Dr. Stuart Jarrett, PhD.
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Figure 3-5. MnSOD protein expression increased after forskolin treatment in
mitochondria.
Human melanocytes MC1R R151C were treated with 10uM Forskolin, 0.1% ETOH
for 1 hour, 50 J UVB and 50uM H2O2. Mitochondria protein was isolated using
sucrose gradient and quantified to be examined by western blot. The relative
MnSOD expression (relative to loading control VDAC) was graphed after forskolin
treatment were normalized to vehicle control.
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A

Figure 3-6. The role of mutated and wild-type MC1R signaling role in the
expression of MnSOD.
HEK 293 were transfected with wild-type MC1R and R160W. The transfected cells
were treated for 1 hour with 10uM forskolin. Whole cell lysates were isolated,
quantified by western blot against indicated-proteins.
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Figure 3-7. HSP70 binds to MnSOD after MC1R activation.
(A) Human melanoma MC1R R151C cell line were treated for 1 hour with 10uM
forskolin or 0.1%ETOH and protein was isolated and IP of FLAG tagged-MnSOD was
performed. Colloidal blue stain was performed and the indicated band was sent for
proteomic identification. (B) Human melanoma MC1R R151C cell line transfected with
FLAG tagged-MnSOD. Then, (C) the cells were treated with 0.1%ETOH and 10uM
forskolin from 1 hour. 50uM H2O2 was added to the indicated samples for 30 min.
Protein was isolated and IP of FLAG tagged-MnSOD was perform followed by a
western blot for HSP70. (C) Whole cell protein (without IP) was included and a western
blot was performed for the loading control FLAG.
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Figure 3-8. FLAG-tagged MnSOD binding to HSP70 is PKA dependent.
(A) Human melanoma MC1R R151C cell line transfected with FLAG tagged-MnSOD
treated with 10uM H89 for 1 hour. Then the cells were treated with 0.1% ETOH, 10uM
Forskolin for an additional 1 hour. 50uM H2O2 was added to the indicated samples for
30 min. Protein was isolated and IP of FLAG tagged-MnSOD was perform followed by
a western blot for HSP70. Input protein (without IP) was included and a western blot
was performed for loading control FLAG or MnSOD.
(B) The PKA kinase assay was performed using recombinant protein HA-MnSOD and
PKA. Both were mixed for 10 minutes and HA-MnSOD was IP and separated in a
SDS-PAGE. Immunoblotting was performed for p-serine.
Panel B was performed by Dr. Stuart Jarrett, PhD.
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Figure 3-9. MnSOD protein activity does not change after forskolin treatment.
Human MC1RR151C melanocytes were treated with 10uM Forskolin and 0.1% ETOH
for 1 to 3 hours. (A) Whole cell protein, (B) whole cell protein plus 1mM potassium
cyanide (KCN) (C) and mitochondria protein plus KCN were isolated and quantified to
be examined by SOD activity assay (Cayman Chemical Co., Ann Harbor, MI.). The
activity of SOD in U/mg was graphed relative to 0 hour control sample. GAPDH was
the loading control for whole cell lysate and VDAC for mitochondria lysate. * p < 0.01
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Figure 3-10. MC1R signaling did not affect mitochondria metabolism.
(A) The percentage and (B) pmol/min concentration of the oxygen consumption rate
(OCR) was measure using the Seahorse Analysis. Human melanocytes MC1R R151C
were treated with 10uM Forskolin, 0.1% ETOH for 1 hour, and 50J UVB. After initial
treatments, the cells were treated with Oligomyocin A, it is an inhibitor of ATP
synthase. FCCP- uncoupled respiration, measure ETC integrity, functionality and
capacity. AA/Rotenone- inhibits mitochondria NADPH dehydrogenase/complex 1 to
test for the pathway of mitochondria metabolism using the Seahorse analysis. The
OCR was quantified per each treatment. The OCR ± SD results are reported as
pmol/min, * p ≤ 0.05 ** p ≤ 0.01.
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DISCUSSION
In this chapter, I hypothesized that MC1R signaling pathway regulates the
expression of antioxidant enzymes. The gene expression in whole skin samples might be
different than purified melanocytes since the skin harbors many different types of cells.
Forskolin is able to rescue MC1R signaling in-vivo, therefore, I took skin biopsies of the
Mc1re/e Tyr+/+ mice treated at different time points with forskolin. There was an increase of
2.5 fold of SOD2 gene expression in the skin samples. However, SOD2 did not show an
increase after isolating primary melanocytes from Mc1re/e Tyr+/+ mice. The presence of
other cell lines in the skin might have a role in the up-regulation of SOD2. It is known that
NF-κB is involved in the immune system and mediates the transcription of SOD2. It is
possible that when melanocytes are isolated from the skin, they lose the interactions with
specific cell types that promote gene expression of SOD in the skin.
Here, I report a protective role of MC1R in the expression of transcription factors,
post-translational regulators and proteins that are part of the oxidative stress pathway.
The 6 hour time point had its higher expression of the transcription factor MITF, a
downstream target of MC1R pathway. Interestingly, genes involved in the base excision
repair pathway such as OGG1 and APEX1 showed no increase at the gene expression.
However, there was a significant increase in the expression of NF-κB, which regulated the
expression of SODs, and an increase in Nrf2 that regulates the expression of glutathione
and glutathione regulating proteins such as GPX1 and GPX3. A 6 hour time point provides
limited information about the mechanism of action by which MC1R increases the protein
levels of these enzymes. However, in support of our hypothesis, it is clear that several
antioxidant enzymes may be up-regulated at the gene level after forskolin induced MC1R
signaling rescue.
SOD2 was not increased after cAMP production in human melanoma cell line
compared to results in mouse melanocytes. Therefore, I hypothesized that there might be
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up-regulation MnSOD at protein levels in MC1R-deficient human melanocytes after
forskolin treatment. Remarkably, MC1R pathway regulated the protein levels of MnSOD
in mitochondria, suggesting a role at the post-translation level since an early time point
(30 minutes) seems inadequate for a transcriptional effect. However, there was a
decrease in the level of GSR and GPX protein levels after the addition of H2O2. This is not
surprising since GSR and GPX are the first line of antioxidant defense after oxidative
injury. A decrease in their protein levels leads to the activation of other antioxidant
enzymes and their regulators. MnSOD is only expressed in the mitochondria, perhaps
explaining why I was not able to observe cAMP-induced differences in whole cell lysate
from human melanocytes. Rather, protein levels of MnSOD were increased only when
mitochondria lysate was isolated.
The transfection of wild-type MC1R in HEK293 cells showed a slight decrease in
the protein levels of MnSOD after MC1R activation with forskolin. Since HEK293 cell line
is not skin specific, it is possible that MnSOD protein levels are regulated differently than
in native melanocytes. One option to clarify this issue would be to inhibit the expression
of MC1R with siRNA in human melanocytes and test for the protein levels of MnSOD
before and after forskolin treatment. Other possibilities to explain high levels of MnSOD in
unstimulated MC1R wild-type melanocytes include ligand-independent MC1R signaling or
altered number of MC1R proteins expressed in the plasma membrane. HSP70 is known
to have a role in the translocation of glutathione to the mitochondria (Guo, Wharton et al.
2007). Surprisingly, this protein interacts with MnSOD after the activation of MC1R
signaling plus H2O2. MC1R deficient human melanocytes that were treated with forskolin
that showed a 3.7 fold increase in MnSOD-associated HSP70 protein levels. However,
there was no difference once H2O2 was added to the cells. Interestingly, immuneprecipitation experiments using FLAG-tagged MnSOD showed an interaction between
MnSOD and HSP70 after forskolin treatment and forskolin plus H2O2. This means that the
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MC1R signaling enhancing the interaction of MnSOD with HSP70 might have a role in the
translocation of MnSOD to the mitochondria. This interaction was lost after adding a PKA
inhibitor. This suggests that the mechanism of this interaction was PKA dependent. Based
in the results on the protein kinase assay, there may be phosphorylation of MnSOD by
PKA at any serine in MnSOD sequence. However, PKA might also have a role in the
regulation of HSP70 as a transporter of MnSOD. Further experiments with recombinant
protein might help to decipher a mechanism. Future experiments would focus on the
identification of specific phosphorylation site(s), mutating them and determining effects on
interactions between MnSOD and HSP70. The study of a possible phosphorylation of
MnSOD increasing its interaction with the chaperone protein HSP70 is a potentially
interesting discovery. However, it is important to consider that the regulation of the
phosphorylation network in the cell requires both kinases and phosphatases and therefore
may be more complex than one single post-translational modification. Although we
focused on PKA since it is a target of cAMP, there are phosphatases that might be target
of cAMP such as protein phosphatase 2A (PPA) which is inhibited by cAMP (Dodge-Kafka,
Bauman et al. 2010) and opens an interesting mechanism of phosphatase regulation by
cAMP that might be relevant in melanocytes.
I hypothesized that the activity of MnSOD was up-regulated after forskolin
treatment in MC1R deficient human cell lines. There was an increase in the removal of
superoxide radical generated by xanthine oxidase after forskolin induced MC1R signaling
in MC1R deficient human melanocytes. These data are consistent with the increase in the
expression of MnSOD in mitochondria after 1 hour of forskolin treatment. Based on these
results, I showed for the first time that MC1R signaling might have a potential role in the
up-regulation of MnSOD activity at early time points.
Moreover, there is a significant increase in maximal respiration comparing UVB
treated cells with UVB plus forskolin-induced MC1R. UVB alone produces a significant
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decrease in maximal respiration and forskolin seems to rescue that decrease. The
analysis of mitochondria phosphorylation is challenging in epidermal melanocytes. This
cell type contains lower levels of mitochondria compared with a muscle cell. Therefore,
the values of this assay were lower than expected at normal rate of mitochondrial
phosphorylation. Nonetheless, based in these results, there is a possible rescue in
maximal respiration after forskolin treatment with or without UVB.
In this chapter, I demonstrated the role of MC1R/cAMP provides protection against
DNA mutagenesis. In addition, MC1R enhances MnSOD levels/activity in mitochondria
and does not affect the mitochondria metabolism as a potential functional effect of the
pathway. MC1R signaling is a potential target for the prevention of UV-induced oxidative
damage in the skin.

Copyright © Alexandra Amaro-Ortiz 2015
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CHAPTER 4
SUMMARY
Pharmacologic activation of the MC1R signaling pathway protects the skin against
UV-induced damage and promotes the activity of the antioxidant enzyme MnSOD.
Individuals with deficiencies in the MC1R signaling pathway can benefit from
pharmacologically-induce melanin production and rescue of MC1R signaling. Dark
melanin is produced in the skin as a protective barrier. The effect is not only seen in UVsensitive Caucasians but also on low-risk individuals of dark skin complexion. The
pharmacologic stimulation of MC1R could be used as a therapeutic target to darken the
skin and protect it against UV damage. The use of a cAMP stimulator in addition to
sunscreen might contribute to a decrease in the incidence of melanoma.
I demonstrated that the activation of MC1R induces several epidermal defenses
that protect the skin against oxidative stress by upregulating antioxidant defenses. Topical
application of forskolin, can directly rescue downstream targets of the MC1R. Interestingly,
I was able to see that by a second application of forskolin, the skin showed an
accumulation of protective melanin, and melanin stayed in the skin as long as topical
forskolin treatment were continued. Taking advantage of our mouse model, I studied the
activation of the MC1R as a protective target against damaging UV doses. MC1R signaling
enhanced antioxidant enzymes that provide protection against oxidative stress. Nrf2 is a
key transcription factor in the regulation of antioxidant enzymes. MC1R increased the
expression of Nrf2 together with several regulators of glutathione activity. I found an
increase in the level of antioxidant enzymes expression after six (6) hours of cAMP
stimulation in human melanocytes. In addition, the rescue of MC1R by forskolin resulted
in an increase of MnSOD translocation to the mitochondria and higher MnSOD activity.
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I studied possible mechanisms of action for cAMP induction of MnSOD. HSP70 is
a chaperone protein that was found to bind to MnSOD. I observed interactions between
MnSOD and HSP70 early after treatment with forskolin. Their interaction was lost when
PKA inhibitor H89 was included. Thus, PKA might have a role by phosphorylating MnSOD
to be recognized and translocated to the mitochondria. Clearly, cAMP-enhanced MnSOD
is PKA-dependent. Figure 4-1 summaries the scope of chapter 2 and 3.

Figure 4-1 Schematic representation of the research project.
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FUTURE DIRECTIONS
Studies link antioxidant defenses to many beneficial effects. Many synthetic and
natural products have been reported to enhance levels of antioxidant enzymes, to prevent
aging symptoms and to target UV-mediated damage. In addition, there are non-enzymatic
antioxidants present in the skin.

Some products that have the potential to induce

antioxidant defenses in the skin include α-tocopherol, selenium, phloretin, ferulic acid,
flavangenol, lipoic acid, and uric acid. I focused in the use of forskolin, a natural product
that had been proved to be harmless as a topical treatment and now there is additional
evidence that confirms its role in the rescue of MC1R and the induction of the protein
levels of the antioxidant enzyme MnSOD.
Additional experiments are needed to determine the mechanisms by which of
MC1R increases MnSOD levels in mitochondria. The proximity ligation assay (PLA) allows
the study of two protein within 11nm proximity. Using this technique, one can to determine
the location of the interaction between MnSOD and HSP70. I reported the inhibition of this
interaction by adding H89. In addition, if the site of phosphorylation is identified, a sitedirected mutagenesis assay can be performed for MnSOD abolishing of the interaction
similar to the use of a PKA inhibitor.
Stimulating cAMP levels in the skin is attractive for a variety of reasons: Increasing
cAMP levels in epidermal melanocytes stimulates pigment synthesis and cutaneous
deposition of melanin. A proof-of-concept study using forskolin has already been shown
in an animal model of the MC1R-deficient human (D'Orazio, Nobuhisa et al. 2006). The
pharmacologic cAMP induction is not mutagenic (as opposed to UV). The use of spray
tanning might be a safe alternative to the use of tanning beds. Sunless tanning would
lessen the need for purposeful UV-seeking behavior among individuals desiring a darker
skin complexion and would thus reduce the frequency of melanocyte mutations.
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Increasing melanocyte cAMP levels may be a highly effective melanoma
prevention strategy. Therefore, there is great interest in developing novel therapeutics to
increase melanocyte cAMP levels in the skin (D'Orazio, Nobuhisa et al. 2006). There are
three major approaches for increasing cAMP in melanocytes in the skin.

The first

mechanism of action is (1) to exploit melanocortin effects on the MC1R using α-MSH or
α-MSH analogues (Haskell-Luevano, Shenderovich et al. 1995, Abdel-Malek, Ruwe et al.
2009, Abdel-Malek 2010, Abdel-Malek, Swope et al. 2014). This approach, particularly
with topically-applied agents, offers the specificity of melanocyte-directed cAMP
stimulation because melanocytes are thought to be the only cells in the skin that express
MC1R. The limitation of MC1R-directed therapies, however, is that they would not be
expected to be effective in the scenario of loss-of-function MC1R mutations and MC1Rdysfunctional individuals are the most UV-sensitive and prone to melanoma.

Thus,

melanocortin-based approaches allows more specificity. Other approaches rely on (2)
pharmacologic induction of adenylyl cyclase activity (e.g. by forskolin), (3) inhibition of
phosphodiesterase activity (e.g. by rolipram) to manipulate melanocyte cAMP levels
defective of MC1R status (D'Orazio, Nobuhisa et al. 2006, Passeron, Namiki et al. 2009,
Spry, Vanover et al. 2009, Khaled, Levy et al. 2010, Scott, Christian et al. 2012, AmaroOrtiz, Vanover et al. 2013, Amaro-Ortiz, Yan et al. 2014). These agents, when applied
topically, would affect cells of various types rather than being targeted only to
melanocytes. Despite their lack of melanocyte specificity, however, these drugs should
work even in individuals with homozygous MC1R loss-of-function and provide such
persons with UV protection and melanoma prevention. The safe pathway will ensure the
safety of melanocyte cAMP stimulation and to design ways of targeting agents to
melanocytes in the skin to limit systemic exposure and off-target effects.

Topical

preparations, for example, offer direct application to the skin, however they may be
challenged by ineffective transdermal penetration of the drug or systemic uptake into the
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circulation from the skin. Lastly, oral or injectable routing may bypass the need for a
transdermal preparation however, systemic effects would be greater. Thus, much work
remains to be done to understand the usefulness and potential consequences of
manipulating cAMP levels in the skin.
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CONCLUSION
Despite a clear understanding of the causative role UV exposure plays in the development
of the disease and widespread public health campaigns to limit time spent in the sun or
artificial tanning beds, melanoma is a growing and significant public health threat. Lossof-function polymorphisms of MC1R signaling, which result in reduced melanocyte cAMP
levels, strongly correlate with fair complexion, a tendency to burn rather than tan and an
increased lifetime melanoma risk. The MC1R/cAMP signaling axis not only leads to the
production of UV-protective melanin, but also enhances melanocytic ability to repair UVdamaged DNA. Pharmacologic induction of MC1R pathway provides protection against
sunburn. When applied to the skin, forskolin potently increases cutaneous cAMP levels
and induces several UV-protective changes in melanocytes.

By promoting melanocyte

genomic stability, topical forskolin may prove to be a useful UV- and melanoma-preventive
strategy.
My work also showed that pharmacologic activation of cAMP/MC1R signaling enhances
expression of antioxidant defenses. I studied the mechanistic links between the
MC1R/cAMP signaling pathway. I explored the relationships between this pro-survival
and pro-differentiation melanocytic signaling pathway and the critical cellular antioxidant
enzymes in the skin. I identified, for the first time a possible binding partner of MnSOD
after oxidative injury, the chaperone protein HSP70. The mechanism of this interaction
might be regulated by PKA, a downstream target of MC1R/cAMP signaling pathway. The
use of natural products has significant potential to lessen UV-induced skin damage. This
project provides a basic scientific rationale for the development of novel UV-preventive
therapeutic agents based on pharmacologic activation of the MC1R/cAMP signaling axis.
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APPENDIX A:

GOLDENROD EXTRACT DECREASES THE ANTI-INFLAMMATORY CAPACITY OF
FAIR-SKINNED MICE AFTER UV-INDUCED ERYTHEMA IN THE SKIN.
INTRODUCTION
The neural nicotinic acetylcholine receptor alpha 7 (nAChRα7) is a four transmembrane
neurotransmitter-gated ion channel (Arredondo, Nguyen et al. 2003). The expression of
α7 subunit in the skin promotes keratinocyte adhesion (Arredondo, Nguyen et al. 2002)
and attenuation of the pro-inflammatory responses after UV-exposure (Osborne-Hereford,
Rogers et al. 2008). The role of this receptor in diseases related to the central nervous
system (CNS) has been widely studied specifically in the regulation of the immune
response. The CNS can modulate the immune system through the cholinergic antiinflammatory pathway (Kurzen, Berger et al. 2004). This pathway suppresses the
synthesis of cytokines utilizing the neurotransmitter acetylcholine (ACh) as an activator of
nAChRα7. ACh is widely distributed and is released in organs of the reticulo-endothelial
system such as the gastrointestinal tract, lungs, and kidney among others.
Epidermal keratinocytes produced ACh. The cholinergic pathway is activated by ACh and
regulates blood circulation, keratinocytes differentiation (Arredondo, Nguyen et al. 2002),
sweat gland formation, and immune reactions. ACh can bind to the nAChRα7 on
macrophages and suppresses the release of cytokines and TNF-α. The nAChRα7 can be
found in peripheral tissues. The expression nAChRα7 is increased in skin wounds (Fan,
Yu et al. 2011). Other studies have focused on how nAChRα7 enhances infiltration of
neutrophils in the skin (Gahring, Osborne et al. 2010).
UV radiation is able to induce an inflammatory response in the skin. High doses of UV,
can lead to a painful sunburn. When the skin is injured, there is a release of cytokines and
chemokine factors to increase permeability and blood flow to the skin. This leads to
82

swelling and redness of the area affected. If the inflammatory response is excessive, this
response can cause harm to cells and surrounding tissues.
Solidago is known as goldenrod and is the state flower of Kentucky. Solidago extract, a
natural product, contains many substances including flavonoids. Flavonoids are known for
their permeability in vascular capillaries increasing the flow of small molecules or even
whole cells to the site of inflammation (Pastore, Potapovich et al. 2009). Oral
administration of flavonoids has been used to reduce allergic inflammatory disease
(Tanaka 2014). In addition, clinical studies have showed positive results in skin elasticity
(Delalle-Lozica 2010).
Solidago extract has been studied as a potential ligand of the nAChRα7 (Lutz, Kulshrestha
et al. 2014). Solidago’s structure contains an alkaloid methyllycaconitine (MLA) complex
that has high affinity for the receptor. It can selectively bind to nAChRα7, leading to its
activation modulating the inflammatory response at the site of injury (Lutz, Kulshrestha et
al. 2014). The nAChRα7 is found in non-neuronal tissues such as the skin. It has a role in
keratinocyte adhesion, cell migration, differentiation and apoptosis (Kurzen, Berger et al.
2004).
Here I studied the role of Solidago extract in skin after UV exposure. Solidago extract is a
natural product that can be administered topically. I tested the capacity of solidago extract
to reduce UV-induced inflammatory responses in the skin using K14-SCF Mc1r-deficient
mice. For this study, the mice used were fair-skinned due to decreased MC1R signaling.
Albino extension mice (Mc1re/e Tyrc2j/c2j) lacking both MC1R signaling and melanin
biosynthesis were also used. I tested the capacity of short-term application of crude
solidago extract to protect against UV-induced sunburn by measuring the minimal
erythematous dose (MED). Moreover, I investigated gene expression in the skin, focusing
on cytokines involved in the inflammatory response.
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SPECIFIC AIM:
To determine the effect of Solidago against UV-induce inflammation of the skin in fairskinned mouse model
1a)

To determine the role of solidago after a short-term topical application.

1b)

To determine the MED after solidago treatment.

1c)

To examine the expression of different cytokines and its receptors in the skin.

METHODS AND MATERIALS
Protocols for murine experiments followed the guidelines for ethical conduct in the care
and use of animals and were approved by the Institutional Animal Care and Use
Committee at the University of Kentucky (Protocol # 00768M2004).
MOUSE COLONY
4 to 12 week old C57BL/6 extension non-transgenic and K14-SCF transgenic extension
males and females mice were used. The characteristic phenotype was blonde fur, pink
skin, dark footpads and nose tip. The mice showed pheomelanotic fur, pheomelanotic
epidermal skin (due to presence of interfollicular epidermal melanocytes).
REAGENTS AND MATERIALS
The following reagents were purchased commercially: Coleus Forskohlii 20% extract
(Buckton Scott USA Inc, Princeton NJ); Depilatory cream Nair (Church & Dwight,
Princeton , NJ); Xylazine (Anased Injection, Shanandoah, IA); Ketamine (Putney, St.
Joseph, MO.); Isothesia Isoflurane (Butler Schein, Dublin, OH); Propyl glycol (Amresco,
Solon, OH) and Ethyl Ethanol (Fisher, Waltham, MA.). The following materials were
purchased commercially: Chromameter CR-400 and data processor (Konica Minolta,
Ramsey, NJ); Electric Shears (Oster, Atlanta, GA); NIST Radiometer/Photometer Model

84

IL1400A, International Light, Newburyport, MA), and Germicidal Hg Lamb UV-B
(Westinghouse, Pittsburgh, PA).
PREPARATION OF SOLIDAGO FOR TOPICAL ADMINISTRATION.
Dr. John Littleton from the College of Pharmacy at the UKY provided the extract for
Solidago. The preparation of Solidago was made by solubilizing the extract 10%
weight/volume in a standard dermatologic base of 70% ethanol, 30% propylene glycol.
SOLIDAGO (GOLDENROD) TOPICAL TREATMENT
The skin biopsies were obtained from MC1Re/e Tyr+/+ C57BL/6 animals unless otherwise
stated. The mice were briefly anesthetized using an intraperitoneal injection of a standard
mixture of ketamine (Putney, St. Joseph, MO.) and xylazine (Butler Schein, Dublin, OH.)
(Typically 0.04 ml per 10g body weight of a mixture of 10 mg/ml ketamine and 1.0 mg/ml
xylazine). The dorsal fur was removed using electric shears equipped with a 0.25mm
surgical preparatory head (Fisher Scientific) followed by chemical depilation by Nair
(Church and Dwight, Princeton, NJ.). After 24 hours, the mice were treated in the dorsal
skin with 400uL of 10 % solidago extract; vehicle control animals received 70% ethanol,
and 30% propylene glycol alone. Twice daily for 3 days (6 applications) or one day
applications were performed for the study. Then, 48 hours after the last topical treatment,
the mice were anesthetized with ketamine and xylazine so that UV sensitivity by
calculation of “Minimal Erythematous Dose” (MED) could be determined. A UV-occlusive
tape was placed on the back of the mice. The mice were placed in a UV source consisting
of two Westinghouse F15T8UV-B lamps with a peak output of 313nm and a range of 280
to 370 nm. The UV dose was based on the UV transmission rate and it was measured by
a UV Photometer. The UV exposure time was calculated for each desired dose based on
the UV output of the source. The mice were monitored for 24 to 48 hours for discreet
areas of erythema (redness) or edema (swelling) corresponding to the anatomic sites
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exposed to the specific dose of UV irradiation.

The skin findings were documented

photographically.
MRNA ISOLATION FROM TISSUE SAMPLES

The skin biopsies were taken at desired time-points. Frozen skin tissues were triturated
using liquid nitrogen with a mortal and pedestal. The skin was homogenized with Trizol®
reagent following manufacturer protocol. The mRNA was clean-up using the RNeasy kit
(Qiagen, Valencia, CA.) following the manufacturer protocol. The pure mRNA was
quantified, normalized and converted to cDNA using the iScript cDNA kit (Qiagen,
Valencia, CA.).
qPCR
The cells were plated in 35mm dishes and treated for cAMP stimulation. Treatments
included 10µM forskolin or 0.1% vehicle control and untreated cells as the control
samples. The cells were dissociated by treatment with 0.25% trypsin/EDTA at 37°C for 5
min. The cells were harvested, centrifuged and RNA was isolated using the RNAeasy kit
(Qiagen, Valencia, CA.). RNA was converted to cDNA using the iScript cDNA kit (Qiagen,
Valencia, CA.). The cDNA was used to perform quantitative PCR assay by the CF-96
Biorad qPCR with the Actin β as a reference gene included for each reaction. The levels
of expression of genes in stimulated cells were compared with the untreated and control
groups.
STATISTICAL ANALYSIS
The data was analyzed between cohorts of replicates samples (n = 3) by one-way ANOVA
using the Bonferroni post-test (Graph Pad PRISM software).
considered statistically significant.
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p values <0.01 were

RESULTS
SOLIDAGO DECREASES MED IN MC1RE/E TYR+/+ MICE AFTER UV-EXPOSURE.
I studied the effects of topical treatment of solidago (goldenrod) extract on preventing UVinduced skin inflammation using the K14-SCF Mc1re/e Tyr+/+ mouse model (Fig 5-1). I
tested the role of Solidago in the skin by measuring minimal erythematous dose, MED.
Topical administration of Solidago extract had no effect on darkening of the skin (Figure
5-2C, D). After applying solidago twice daily for 3 days (10% Solidago per dose), the
average MED for K14-SCF extension (Mc1r

e/e

Tyr +/+) mice was significantly higher with

10.0 ± 0.0 kJ/m2 compared to 4.0 ± 0.0 kJ/m2 for the vehicle control treated group (Fig. 52 C). The average MED in K14-SCF albino extension (Mc1r e/e Tyr c2j/c2j) mice treated with
solidago and vehicle were 3.3 ± 1.2 kJ/m2 and 0.8 ± 0.4 kJ/m2, respectively (Fig. 5-2 D).
There was no significant difference in the erythema of the skin for albino extension mice
treated with solidago. Here I concluded that Solidago decreased UV-induced inflammation
in fair-skinned mice.
ONE TOPICAL TREATMENT OF SOLIDAGO IN MC1RE/E TYR+/+ MICE AFTER UV-EXPOSURE DID
NOT DECREASE MED.

I performed another experiment with only one application of 10% solidago followed by UVexposure in K14-SCF extension (Mc1r

e/e

Tyr +/+) mice (Figure 5-3). Two groups of mice

were pretreated with solidago for 3 or 6 hours before UV exposure. The average MED for
the 3 hours group was 2.0 ± 0.0 kJ/m2 for both solidago and vehicle control. However, for
the mice irradiated 6 hours after solidago treatment, the MED was 4.0 ± 0.0 kJ/m2
compared to 2.0 ± 0.0 kJ/m2 for vehicle control (Figure 5-3B). Although the MED was
decreased, these results were not significant. There was no significant difference in both
groups. I concluded that one application of 10% solidago was not enough to promote an
anti-inflammatory response.
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SOLIDAGO DECREASE THE INFLAMMATORY RESPONSE AT LOWER DOSES OF UVB.
I performed a gene array for the expression of several cytokines and its receptors that are
involved in the inflammatory response. Solidago was applied twice daily for 3 days (10%
Solidago per dose), to measure MED for K14-SCF albino extension. Doses of 2kJ/m2 and
6 kJ/m2 were used for gene analysis. These doses of UV elicit a low and high inflammatory
response in the mouse skin. The MED of K14-SCF albino extension (Mc1r

e/e

Tyr c2j/c2j)

was measured 48 hours after UV-exposure. The 48 hour time-point was selected to
analyze 60 genes that include inflammatory cytokines and its receptor. Out of the genes
tested, there were 24 chemokines, 7 chemokine receptors, 7 interleukins, 9 interleukins
receptors and others 13 cytokines and its receptors. Of these, there was a decrease in
the expression of the majority of pro-inflammatory genes after Solidago treatment
compared to vehicle control and a 2 kJ/m2 dose. There was a decrease in the expression
of several cytokines (Ccl1, Cx3cl1, IL15 family among other genes relative to the
expression of Actb) (Table 5-1), but there were significant increases in the expression of
IL1r1, and Tnfsf13. I noted an increase in the gene expression of several genes after a 6
kJ/m2 exposure. There was an even higher increase in the expression of IL1r1 and Tnfsf13
were increased by 2 and 6 fold respectively, relative to vehicle. Ccl11 and Cxcl15 had a 2
and 7 fold increase after Solidago treatment, respectively (Table 5-1). Thus, I concluded
that topically-applied Solidago decreased the inflammatory response at low doses of UVexposure.
SOLIDAGO DECREASES Tnf-α SIGNALING IN MC1RE/E TYR+/+ MICE AFTER UV-EXPOSURE.
Previous studies showed the expression of three specific genes as key targets for the
inflammatory response (Osborne-Hereford, Rogers et al. 2008). Therefore, I tested the
expression of Tnf-α, IL1β and IL6 (Figure 5-4) in K14-SCF albino extension. The skin
biopsies were taken after irradiating the skin with 2 or 6 kJ/m2 of UV. For a low dose of 2
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kJ/m2, there was a decrease in the gene expression of Tnf-α and IL1β after treatment of
10% solidago compared to vehicle control. But, there was an increase of 4 fold for the
gene expression of IL6 after solidago.
Interestingly, for the 6kJ/m2, there was an increase of 4 fold for IL1β comparing vehicle
with solidago treatment. The gene expression of IL6 increased 9 fold after solidago
treatment. However, Tnf-α gene expression was decreased 2 fold after solidago
treatment. The inhibition of the inflammatory response mediated by solidago may be
dependent of the expression of Tnf-α.
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Figure 5-1. Topical treatment of Solidago in fair-skinned extension and
albino extension mice.
(Mc1re/e) mice photographs of C57BL/6 animals were used in this study. Animals
were genetically matched except at the melanocortin 1 receptor (Mc1r) and
Tyrosinase (Tyr) loci. Note that pigmentation is pheomelanotic (blond) when Tyr
is functional but amelanotic (albino) when Tyr is defective, as is the case with the
albino extension (Mc1re/e Tyrc2j/c2j) mutant. (B) Epidermal pigmentation depends
on retention of interfollicular epidermal melanocytes in the skin by the K14-SCF
transgene, and the skin darkening can easily be seen in the ears.
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Figure 5-2. Solidago protected against UV-mediated inflammation as
determined by minimal erythematous dose (MED) testing.
(A, C) Position of UV occlusive tape and UVB doses of animals treated twice daily
for 3 days with 10 % solidago and vehicle control (70% ethanol 30% propyl glycol).
Dorsal skin was exposed to various doses of UVB by using UV-occlusive tape
with punched-out 1 cm2 circular apertures, and varying exposure times to yield
the appropriate dose. (B, D) Mc1re/e Tyr+/+ and Mc1re/e Tyrc2j/c2j were irradiated after
the completion of the last treatment (6 applications). After irradiation, circles of
exposed skin were labeled with a pen in some experiments. MED’s, defined by
erythema and/or edema in the entire circle of exposed skin to a particular dose,
were determined 48 hours after exposure. The MED ± SD results are reported as
kJ/m2 UVB, p ≤ 0.001.
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Figure 5-3. Solidago protected against UV-mediated inflammation as
determined by minimal erythematous dose (MED) testing.
(A) Position of UV occlusive tape and UVB doses of animals once one day with
10 % solidago and vehicle control (70% ethanol 30% propyl glycol). Dorsal skin
was exposed to various doses of UVB by using UV-occlusive tape with punchedout 1 cm2 circular apertures, and varying exposure times to yield the appropriate
dose. (B) Mc1re/e Tyr+/+ mice were treated with solidago 3 and 6 hours prior to UV
exposure. After irradiation, circles of exposed skin were labeled with a pen in
some experiments. MED’s, defined by erythema and/or edema in the entire circle
of exposed skin to a particular dose, were determined 48 hours after
exposure. The MED ± SD results are reported as kJ/m2 UVB, * p ≤ 0.001.
Experiment performed in collaboration with Kaia Hampton.
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Table 5-1. Cytokines gene array, the expression of different genes after
solidago treatment.
Mc1re/e Tyr2j/c2j albino extension were treated with 10%w/v Solidago and vehicle
control (70% ETOH, 30% PG) twice daily for 3 days. Skin biopsies were taken after
48 hours of exposure to 2 or 6 kilojoules of UVB. mRNA was isolated to be analyzed
by qPCR using RT2 Profiler PCR Array for inflammatory cytokines and receptors
(Qiagen, Valencia, CA.) with primers specific for mouse mRNA. The gene
amplification was normalized to Actin β and the relative amplification levels at both
UVB doses were compared to vehicle control.
Experiment performed in collaboration with Kaia Hampton.
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Figure 5-4. Solidago inhibited Tnf-α
inflammation.

expression after

UV-induced

Mc1re/e Tyrc2j/c2j albino extension were treated with 10%w/v Solidago and vehicle
control (70% ETOH, 30% PG) twice daily for 3 days. Skin biopsies were taken
after 48 hours of exposure to 2 or 6 kJ/m2 of UVB. mRNA was isolated to be
analyzed by qPCR using RT2 Profiler PCR Array for inflammatory cytokines and
receptors (Qiagen, Valencia, CA.) with primers specific for mouse mRNA. The
gene amplification was normalized to Actin β (Actb) and the relative amplification
levels at both UVB doses were compared to vehicle control.
Experiment performed in collaboration with Kaia Hampton.
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DISCUSSION
The anti-inflammatory response of solidago is mediated by its binding to nAChRα7
This receptor has been found to be expressed in the skin (Zia, Ndoye et al. 2000,
Arredondo, Nguyen et al. 2002, Bencherif, Lippiello et al. 2011, Fan, Yu et al. 2011). I
hypothesized that the solidago extract would protect against UV-inflammation in K14-SCF
Mc1re/e Tyr+/+ and Mc1re/e Tyrc2j/c2j mice. This is the first study using a topical formulation
of solidago. I confirmed my hypothesis in C57BL/6 extension (Mc1re/e Tyr+/+) mice. I was
not able to observe darkening of the skin after 6 applications of the solidago extract on the
back of the mice in contrast to forskolin, which induced darkening of the skin after two
topical applications. This was not a surprise since the effects of solidago are known to
affect inflammatory response rather than pigmentation. However, there was a protective
effect against erythema with a 4.0 kJ/m2 compared to 10.0 kJ/m2 in Mc1re/e Tyr+/+ fairskinned mice. I tested the drug in Mc1re/e Tyrc2j/c2j albino extension mice but the increase
in MED was not significant. Perhaps, the presence of pheomelanin may have a protective
effect against UV-induced inflammation in the skin. To address these differences, further
experiments are required with more mice or a higher percentage of solidago extract in the
skin. The UV exposure of the Mc1re/e Tyrc2j/c2j albino extension was lower (0.5 to 6.0 kJ/m2)
from Mc1re/e Tyr+/+ extension (1.0 to 10 kJ/m2) because amelanotic albino show more UV
sensitivity. I was not able to test higher doses of UV, for the reason that without the
darkening of the skin, higher doses of UV would harm the mice and cause excessive
sunburn.
The use of solidago in both extension and albino extension mice, promoted
decreases in the inflammatory response. The solidago extract has shown no physiological
effect after treatment in mice (Bucciarelli, Minetti et al. 2010). Application of solidago for
only one day show no significant effect protecting against UV-inflammation of the skin.
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Other studies using chronic treatment (more than 3 days) of topical solidago are needed
to study its effect inhibiting the inflammatory response.
Based on the results above, the mechanism of solidago-induced protection is
melanin-independent. Skin samples taken from Mc1re/e Tyrc2j/c2j albino extension mice
were tested for the expression of several genes involved in the inflammatory response.
The gene expression of the majority of cytokines and receptors was decreased at low UV
but not at 6 kJ/m2 suggesting a protective threshold. However, the expression of IL1r1
and Tnfsf13 was increased in both doses. These cytokines have been used as a target to
test inhibition of the inflammatory response (Li, Pappas et al. 2013, Garcia-Perez, Allaeys
et al. 2014, Tsai, Tung et al. 2015). The use of flavonoids such as solidago might yield
protective effects after UV exposure perhaps more effective at lower doses of UV.
The inflammatory response consists of many cytokines receptors. An example of
pro-inflammatory cytokines include IL23, IL17, IL6, IL8, IL10, and Tnf-α among others. IL6
is expressed in severe skin sunburn (Norval 2001, Norval 2011). IL6 promotes the release
of Tnf-α, IL12, IL1 and other cytokines promoting inflammation. IL6 showed a high
expression when tested in the skin treated with 6 kJ/m2 of UV radiation on albino extension
mice confirming its role in skin sunburn. Tnf-α is a pro-inflammatory cytokine and solidago
decreased it at both low and high doses of UV. On the other hand, there are antiinflammatory cytokines like IL13, IL11, and IL4. IL4 and IL13 known to promote tissue
repair together with the production of specific antibodies (Voehringer 2013), therefore
some beneficial effects of inflammation may be lost by Solidago treatment.
I also noted decreases in the expression of Tnf-α and IL1β after solidago treatment
at lower doses of UVB. The decrease remained after increasing the dose of UVB to 6
kJ/m2 for Tnf-α. However, IL1β and IL6 showed an increase in the expression after an
exposure of 6 kJ/m2. This dose of UVB showed an increase in skin redness of the mice.
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The protective effect of solidago at higher doses of UVB might be linked to the regulation
of Tnf-α. Remarkably, Tnf-α is known to regulate dendritic and macrophages density in
the immune response (Marble, Gordon et al. 2007) and IL6 can inhibit endotoxin-induced
Tnf-α signaling (Starkie, Ostrowski et al. 2003). Additional studies are required to
determine if solidago can directly regulate IL6 as an anti-inflammatory cytokine.
The use of solidago for the prevention of inflammation after UVB exposure would
potentially be of benefit to individuals with UV sensitivity. It is important to consider that
the solidago extract contains many other components that might have a role in the skin
response. Therefore, further studies are needed to understand the absorption of this drug
in the skin and to clarify which components are inflammation regulators. Better absorption
might allow more significant results at higher doses of UV. It would be ideal to observe an
anti-inflammatory effect using less than 6 application of solidago (in a matter of hours).
I hypothesized that solidago acted as an agonist to the nAChrα7 to decrease
cytokine production. Although nAChRα7 has been implicated in wound healing (Fan, Yu
et al. 2011) and skin infection (Gahring, Osborne et al. 2010), its pharmacologic activation
in the absence ACh or parasympathetic innervation is a novel mechanism. The nAChRα7
being expressed in non-neuronal locations regulates early local inflammatory responses
in the skin. This suggests that the effect of this receptor might be beneficial even without
UV-exposure. In support of our hypothesis, it is clear that several pro-inflammatory
cytokines were down-regulated at the gene level after topical application of solidago
activates nAChRα7 response and inhibits the inflammatory response.
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APPENDIX B:
PERMISSION LETTER TO RE-USE FIGURES
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APPENDIX C:
LIST OF ABBREVIATIONS
6-4 PP
8-oxoG
A
ACTB
ADIPOQ
ADP
AGTR1
AIMP1
AKT1
APEX1
APOA1
APP
ARE
ATF2
ATP
ATP
B2M
BCL2
BMP2
C
cAMP
CASP3
CAT
CCL1
CCL11
CCL12
CCL17
CCL19
CCL2
CCL20
CCL22
CCL24
CCL3
CCL4
CCL5
CCL6
CCL7
CCL8
CCL9
CCR1
CCR10
CCR2
CCR3
CCR4
CCR5

6-4 photoproduct
8-oxoguanine
adenine
Actin, beta
adiponectin, C1Q and collagen domain containing
Adenosine diphosphate
angiotensin II receptor, type 1
Aimp1 Aminoacyl tRNA synthetase complex-interacting
multifunctional protein 1
v-akt murine thymoma viral oncogene homolog 1
nuclease (multifunctional DNA repair enzyme) 1
apolipoprotein A-I
amyloid beta (A4) precursor protein
antioxidant respose element
activating transcription factor 2
adenosine triphosphate
Adenosine triphosphate
B2m Beta-2 microglobulin
B-cell CLL/lymphoma 2
Bmp2 Bone morphogenetic protein 2
cytosine
3’-5’-cyclic adenosine monophosphate
caspase 3, apoptosis-related cysteine peptidase
catalase
Chemokine (C-C motif) ligand 1
Chemokine (C-C motif) ligand 11
Chemokine (C-C motif) ligand 12
Chemokine (C-C motif) ligand 17
Chemokine (C-C motif) ligand 19
Chemokine (C-C motif) ligand 2
Chemokine (C-C motif) ligand 20
Chemokine (C-C motif) ligand 22
Chemokine (C-C motif) ligand 24
Chemokine (C-C motif) ligand 3
Chemokine (C-C motif) ligand 4
Chemokine (C-C motif) ligand 5
Chemokine (C-C motif) ligand 6
Chemokine (C-C motif) ligand 7
Chemokine (C-C motif) ligand 8
Chemokine (C-C motif) ligand 9
Chemokine (C-C motif) receptor 1
Chemokine (C-C motif) receptor 10
Chemokine (C-C motif) receptor 2
Chemokine (C-C motif) receptor 3
Chemokine (C-C motif) receptor 4
Chemokine (C-C motif) receptor 5
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CCR6
CCR8
CD36
CD40LG
CLU
CPD
CREB
CSF1
CSF2
CSF3
Cu/ZnSOD
CX3CL1
CXC12
CXCL1
CXCL10
CXCL11
CXCL13
CXCL15
CXCL5
CXCL9
CXCR2
CXCR3
CXCR5
CYBA
CYCS
CYP2E1
DCT
DDIT3
DHCR24
DHICA
ECSOD
EGFR
F3
FASL
FBS
FOXO1
G6PD
GAPDH
GAPDH
GCLC
GCLM
GLRX
GLRX2
GPCR
GPX1
GPX3
GPX4
GSH
GSR
GSTP1
GUSB

Chemokine (C-C motif) receptor 6
Chemokine (C-C motif) receptor 8
molecule (thrombospondin receptor)
CD40 ligand
clusterin
cyclobutane pyrimidine dimer
cAMP response element binding
Colony stimulating factor 1 (macrophage)
Colony stimulating factor 2 (granulocyte-macrophage)
Colony stimulating factor 3 (granulocyte)
copper/zinc superoxide dismutase
Chemokine (C-X3-C motif) ligand 1
Chemokine (C-X-C motif) ligand 12
Chemokine (C-X-C motif) ligand 1
Chemokine (C-X-C motif) ligand 10
Chemokine (C-X-C motif) ligand 11
Chemokine (C-X-C motif) ligand 13
Chemokine (C-X-C motif) ligand 15
Chemokine (C-X-C motif) ligand 5
Chemokine (C-X-C motif) ligand 9
Chemokine (C-X-C motif) receptor 2
Chemokine (C-X-C motif) receptor 3
Chemokine (C-X-C motif) receptor 5
cytochrome b-245, alpha polypeptide
cytochrome c, somatic
cytochrome P450, family 2, subfamily E, polypeptide 1
dopachrome tautomerase
DNA-damage-inducible transcript 3
24-dehydrocholesterol reductase
5,6-dihydroxyindole-carboxylic acid
extracellular superoxide dismutase
epidermal growth factor receptor
coagulation factor III (thromboplastin, tissue factor)
Fas ligand (TNF superfamily, member 6)
Fetal Bovine Serum
forkhead box O1
glucose-6-phosphate dehydrogenase
Glyceraldehyde-3-phosphate dehydrogenase
glyceraldehyde-3-phosphate dehydrogenase
glutamate-cysteine ligase, catalytic subunit
glutamate-cysteine ligase, modifier subunit
glutaredoxin (thioltransferase)
glutaredoxin 2
g-protein coupled receptor
glutathione peroxidase 1
glutathione peroxidase 3 (plasma)
glutathione peroxidase 4 (phospholipid hydroperoxidase)
glutathione
glutathione reductase
glutathione S-transferase pi 1
Glucuronidase, beta
100

H2O2
HIF1A
HMOX1
HP
HPRT1
HSP90A1
HSPD1
IFNG
IL10RA
IL10RB
IL11
IL13
IL15
IL16
IL17A
IL17B
IL17F
IL1A
IL1B
IL1B
IL1R1
IL1RN
IL21
IL27
IL2RB
IL2RG
IL3
IL33
IL4
IL5
IL5RA
IL6
IL6RA
IL6ST
IL7
INS
IP
JAK2
JUN
kDA
LCN2
LDHA
LTA
LTB
MAP3K5
MAPK1
MAPK8
MAPK9
MC1R
α-MSH

Hydrogen Peroxide
hypoxia inducible factor 1, alpha subunit (basic helix-loophelix transcription factor)
heme oxygenase (decycling) 1
haptoglobin
hypoxanthine phosphoribosyltransferase 1
Heat shock protein 90 alpha (cytosolic), class B member 1
heat shock 60kDa protein 1 (chaperonin)
Interferon gamma
Interleukin 10 receptor, alpha
Interleukin 10 receptor, beta
Interleukin 11
Interleukin 13
Interleukin 15
Interleukin 16
Interleukin 17A
Interleukin 17B
Interleukin 17F
Interleukin 1 alpha
Interleukin 1 beta
Interleukin 1, beta
Interleukin 1 receptor, type I
Interleukin 1 receptor antagonist
Interleukin 21
Interleukin 27
Interleukin 2 receptor, beta chain
Interleukin 2 receptor, gamma chain
Interleukin 3
Interleukin 33
Interleukin 4
Interleukin 5
Interleukin 5 receptor, alpha
Interleukin 6 (interferon, beta 2)
Interleukin 6 receptor, alpha
Interleukin 6 signal transducer
Interleukin 7
insulin
Intraperitoneal
Janus kinase 2
proto-oncogene
Kilodalton
lipocalin 2
lactate dehydrogenase A
Lymphotoxin A
Lymphotoxin B
mitogen-activated protein kinase kinase kinase 5
mitogen-activated protein kinase 1
mitogen-activated protein kinase 8
mitogen-activated protein kinase 9
melanocortin 1 receptor
alpha melanocyte stimulating hormone
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MDM2
MED
MGDC
MIF
MIF
Mitf
MnSOD
MPO
MSRA
mtDNA
NAMPT
NFE2L2
NFKB1
NMSC
NOS1
NOX1
NQO1
Nrf2
OGG1
OLR1
OSM
PARK7
PBS
PF4
PKA
POMC
PON2
PRDX1
PRDX2
PRDX3
PRDX4
PRDX5
PRDX6
PRKAA2
PRKCA
PRKCB
PRKCD
PRKCZ
PRODH
PTGS2
RELA
RHC
RNS
ROS
ROS1
SCF

p53 binding protein homolog (mouse)
minimal erythemal dose
Mouse Genomic DNA Contamination
Macrophage migration inhibitory factor
macrophage migration inhibitory factor (glycosylationinhibiting factor)
micropthalmia transcription factor
manganese superoxide dismutase
myeloperoxidase
methionine sulfoxide reductase A
mitochondrial DNA
Nicotinamide phosphoribosyltransferase
nuclear factor (erythroid-derived 2)-like 2
nuclear factor of kappa light polypeptide gene enhancer in
B-cells 1
non-melanoma skin cancer
nitric oxide synthase 1 (neuronal)
NADPH oxidase 1
NAD(P)H dehydrogenase, quinone 1
Nuclear factor-like 2
8-oxoguanine DNA glycosylase
oxidized low density lipoprotein (lectin-like) receptor 1
Oncostatin M
Parkinson disease (autosomal recessive, early onset) 7
Phosphate Buffer Saline
Platelet factor 4
protein kinase A
proopiomelanocortin
paraoxonase 2
peroxiredoxin 1
peroxiredoxin 2
peroxiredoxin 3
peroxiredoxin 4
peroxiredoxin 5
peroxiredoxin 6
protein kinase, AMP-activated, alpha 2 catalytic subunit
protein kinase C, alpha
protein kinase C, beta
protein kinase C, delta
protein kinase C, zeta
proline dehydrogenase (oxidase) 1
prostaglandin-endoperoxide synthase 2 (prostaglandin
G/H synthase and cyclooxygenase)
v-rel reticuloendotheliosis viral oncogene homolog A
(avian)
red hair color phenotype
reactive nitrogen species
reactive oxygen species
c-ros oncogene 1, receptor tyrosine kinase
stem cell factor
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SERPINE1
SHC1
protein 1
SIRT1
SNCA
SOD
SOD1
SOD2
SOD3
SPP1
SRC
STAT1
TBS-T
TLR4
TNF
TNFRSF11B
TNFSF10
TNFSF11
TNFSF13
TNFSF13B
TNFSF4
TP53
TXNIP
TXNRD1
Tyr
Trp1
Trp2
UCP1
UCP2
UV
UVA
UVB
UVC
VDAC
VEGFA
XO

serpin peptidase inhibitor, clade E (nexin, plasminogen
activator inhibitor type 1), member 1
SHC (Src homology 2 domain containing) transforming
sirtuin 1
synuclein, alpha (non A4 component of amyloid precursor)
superoxide dismutase
superoxide dismutase 1, soluble
superoxide dismutase 2, mitochondrial
superoxide dismutase 3, extracellular
Spp1 Secreted phosphoprotein 1
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene
homolog (avian)
signal transducer and activator of transcription 1, 91kDa
tris buffered saline – tween 20
toll-like receptor 4
Tumor necrosis factor
Tumor necrosis factor receptor superfamily, member 11b
(osteoprotegerin)
Tumor necrosis factor (ligand) superfamily, member 10
Tumor necrosis factor (ligand) superfamily, member 11
Tumor necrosis factor (ligand) superfamily, member 13
Tumor necrosis factor (ligand) superfamily, member 13b
Tumor necrosis factor (ligand) superfamily, member 4
tumor protein p53
thioredoxin interacting protein
thioredoxin reductase 1
tyrosinase
tyrosine related protein 1
tyrosine related protein 2
uncoupling protein 1
uncoupling protein 2 (mitochondrial, proton carrier)
ultraviolet
ultraviolet A
ultraviolet B
ultraviolet C
voltage-dependent anion channel
Vascular endothelial growth factor A
xanthine oxidase
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